18 results for: psoriasis

• Indicated for the treatment of adult patients with active psoriatic arthritis.
• Indicated for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
• Indicated for the treatment of adult patients with oral ulcers associated with Behçet’s disease.

Document title: Otezla (apremilast) prescribing information. Document link: https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf Document source: Amgen Inc., Thousand Oaks, CA Document type: Product Monograph / Prescribing Information Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Document link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011535.pub6/full Document source: Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Apremilast in palmoplantar psoriasis and palmoplantar pustulosis: a systematic review and meta-analysis. Document link: https://link.springer.com/content/pdf/10.1007/s13555-022-00877-w.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. Document link: https://ard.bmj.com/content/82/1/142.long Document source: Annals of Rheumatic Diseases Document type: Clinical Practice Guidelines Document year: 2023

Document title: Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272578/pdf/fimmu-14-1180170.pdf Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: The efficacy and safety of tyrosine kinase 2 inhibitor deucravacitinib in the treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570425/pdf/fmed-10-1264667.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety of apremilast monotherapy in moderate-to-severe plaque psoriasis: a systematic review and meta-analysis. Document link: https://onlinelibrary.wiley.com/doi/10.1111/dth.15544 Document source: Dermatologic Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials. Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589065/ Document source: Frontiers in immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: a systematic review and meta-analysis. Document link: https://academic.oup.com/mr/article-abstract/32/6/1153/6424467?redirectedFrom=fulltext&login=false Document source: Modern Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparison of psoriasis guidelines for use of apremilast in the United States and Europe: a critical appraisal and comprehensive review. Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1770176 Document source: The Journal of Dermatological Treatment Document type: Clinical Practice Guidelines Document year: 2022

Document title: Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase-4 inhibitors. Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.18810 Document source: Journal of the European Academy of Dermatology & Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Combination therapy with apremilast and biologics for psoriasis: a systematic review. Document link: https://link.springer.com/article/10.1007/s40257-022-00703-1 Document source: American Journal of Clinical Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Apremilast in psoriasis patients with serious comorbidities: a case series and systematic review of literature. Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681161/ Document source: Dermatology Practical & Conceptual Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics and small molecule inhibitors for treating hidradenitis suppurativa: a systematic review and meta-analysis. Document link: https://www.mdpi.com/2227-9059/10/6/1303 Document source: Biomedicines Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year. Document link: https://www.tandfonline.com/doi/pdf/10.1080/09546634.2020.1743811 Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Time to relapse after discontinuing systemic treatment for psoriasis: a systematic review. Document link: https://link.springer.com/content/pdf/10.1007/s40257-022-00679-y.pdf Document source: American Journal of Clinical Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Expert recommendations for the use of apremilast in psoriatic arthritis. Document link: https://www.sciencedirect.com/science/article/pii/S2173574322000922/pdfft?md5=2a1beea9e1af9eece8549277845dfad8&pid=1-s2.0-S2173574322000922-main.pdf Document source: Reumatología Clínica Document type: Clinical Practice Guidelines Document year: 2022

Document title: Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis. Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17520 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Joint American Academy of Dermatology - National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2820%2930284-X Document source: Journal of the American Academy of Dermatology Document type: Clinical Practice Guidelines Document year: 2020

Document title: EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris - part 1: treatment and monitoring recommendations. Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16915 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2020

Document title: EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Document link: https://ard.bmj.com/content/annrheumdis/79/6/700.1.full.pdf?with-ds=yes Document source: Annals of the Rheumatic Diseases Document type: Clinical Practice Guidelines Document year: 2020

Document title: Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis. Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046955/ Document source: Rheumatic & Musculoskeletal Diseases Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative. Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850142/ Document source: Rheumatology Advances in Practice Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Therapeutic options for patients with rare rheumatic diseases: a systematic review and meta-analysis. Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603763/pdf/13023_2020_Article_1576.pdf Document source: Orphanet Journal of Rare Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparability of European League Against Rheumatology-recommended pharmacological treatments of oral ulcers associated with Behçet’s disease: a systematic literature review of randomized controlled trials. Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762439/pdf/oarrr-12-323.pdf Document source: Open Access Rheumatology: Research and Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologics and small molecules in patients with scalp psoriasis: a systematic review. Document link: https://www.tandfonline.com/doi/abs/10.1080/09546634.2020.1770167?journalCode=ijdt20 Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response. Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587780/pdf/JDV-33-355.pdf Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Time until onset of action when treating psoriatic arthritis: meta-analysis and novel approach of generating confidence intervals. Document link: https://link.springer.com/article/10.1007%2Fs00296-019-04244-5#article-info Document source: Rheumatology International Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: a systematic review and network meta-analysis. Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017219300447?via%3Dihub Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults. Document link: https://www.sfdermato.org/upload/recommandations/psoreco-72474f007184bd36c0e70cb2d89e5fd2.pdf Document source: Journal of the European Academy of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2019

Document title: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Document link: https://www.rheumatology.org/Portals/0/Files/PsA-Guideline-2018.pdf Document source: Arthritis & Rheumatology Document type: Clinical Practice Guidelines Document year: 2019

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: a systematic review and network meta-analysis. Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017219300447?via%3Dihub Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Comparison of the efficacy and safety of tofacitinib and apremilast in patients with active psoriatic arthritis: a Bayesian network meta-analysis of randomized controlled trials. Document link: https://link.springer.com/article/10.1007/s40261-019-00765-w Document source: Clinical Drug Investigation Document type: Systematic Reviews / Meta-Analyses Document year: 2019

• Indicated for the treatment of adult patients with moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy
• Indicated for the treatment of adult patients with active psoriatic arthritis (PsA)
• Indicated for the treatment of pediatric patients 6 years and older with moderate to severe plaque psoriasis, who are candidates for phototherapy or systemic therapy
• Indicated for the treatment of pediatric patients 6 years and older with active psoriatic arthritis (PsA).

Document title: Selarsdi (ustekinumab-aekn) Prescribing Information. Document link: https://tevauscommercial.tevapharm.com/globalassets/selarsdi/prescribing-information.pdf Document source: Teva Pharmaceuticals Parsippany, NJ Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis Document link: https://www.cghjournal.org/action/showPdf?pii=S1542-3565%2823%2900767-X Document source: Clinical gastroenterology and hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review Document link: https://journals.sagepub.com/doi/pdf/10.1177/12034754241260023 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden Document link: https://www.tandfonline.com/doi/epdf/10.1080/13696998.2023.2259609?needAccess=true Document source: Journal of Medical Economics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125768/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148207/pdf/ptt-12-99.pdf Document source: Psoriasis Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Adverse Effects of Anti-Interleukin-23 Agents Employed in Patients with Psoriasis: A Systematic Review Document link: https://karger.com/drm/article/238/5/886/823440/Adverse-Effects-of-Anti-Interleukin-23-Agents Document source: Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and safety of biological agents for the treatment of pediatric patients with psoriasis: A bayesian analysis of six high-quality randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446895/pdf/fimmu-13-896550.pdf Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608970/pdf/pharmaceutics-14-02140.pdf Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017712/pdf/fphar-13-847308.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics. Document link: https://www.minervamedica.it/en/getfreepdf/L1BkdUl3VVdDaitaSUZETVhUcW5ZS3NzT3EyeW1KYkFEa0lxOFRUZUdMQmFtOUR4SWdVb3pMWFVUTVU2ZnYvLw%253D%253D/R23Y2022N06A0469.pdf Document source: Italian Journal of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1743811?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2021.1892024?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056462/pdf/12325_2022_Article_2065.pdf Document source: Advances in Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials Document link: https://www.jidonline.org/action/showPdf?pii=S0022-202X%2821%2901149-0 Document source: The Journal of Investigative Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408312/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391184/pdf/jmcp.2021.27.1.084.pdf Document source: Journal of Managed Care & Specialty Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis Document link: https://www.jdsjournal.com/action/showPdf?pii=S0923-1811%2820%2930199-7 Document source: Journal of Dermatological Science Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes Document link: https://www.clinexprheumatol.org/abstract.asp?a=14325 Document source: Clinical and Experimental Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046955/pdf/rmdopen-2019-001117.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcpt.13153 Document source: Journal of clinical Pharmacy and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis Document link: https://pubmed.ncbi.nlm.nih.gov/32521069/ Document source: Dermatologic therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis Document link: https://journals.sagepub.com/doi/10.1177/1203475420933174?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review Document link: https://journals.sagepub.com/doi/10.1177/1203475419897578?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review Document link: https://jamanetwork.com/journals/jamadermatology/article-abstract/2769110 Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494414/pdf/cureus-0012-00000009812.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title:  Japanese guidance for use of biologics for psoriasis (the 2019 version) Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.15196 Document source: The Journal of Dermatology Document type: Clinical Practice Guidelines Document year: 2020

Document title: Biologic therapies targeting the interleukin (IL)-23/IL-17 immune axis for the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.15879 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate-to-severe plaque psoriasis: the COMPASS analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496582/pdf/BJD-183-276.pdf Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933315-8 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956468/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017219300447?via%3Dihub Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Treatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S1567576919312445?via%3Dihub Document source: International immunopharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754904/pdf/JIR2019-2546161.pdf Document source: Journal of Immunology Research Document type: Systematic Reviews / Meta-Analyses Document year: 2019

• Indicated for rheumatoid arthritis (RA): reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA
• Indicated for juvenile idiopathic arthritis (JIA): reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older
• Indicated for psoriatic arthritis (PsA): reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA
• Indicated for ankylosing spondylitis (AS): reducing signs and symptoms in adult patients with active AS
• Indicated for Crohns disease (CD): treatment of moderately to severely active Crohns disease in adults and pediatric patients 6 years of age and older
• Indicated for ulcerative colitis (UC): treatment of moderately to severely active ulcerative colitis in adult patients
• Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers
• Indicated for plaque psoriasis (Ps): treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate
• Indicated for hidradenitis suppurativa (HS): treatment of moderate to severe hidradenitis suppurativa in adult patients
• Indicated for uveitis (UV): treatment of non-infectious intermediate, posterior, and panuveitis in adults patients.

Document title: Efficacy and safety of adalimumab in pediatric patients with Crohn's disease: A systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10873464/pdf/228_2023_Article_3613.pdf Document source: European Journal of Clinical Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: An Overview of Adalimumab Therapy for Ankylosing Spondylitis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11340288/pdf/CRR-20-501.pdf Document source: Current Rheumatology Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11103324/pdf/ard-2024-225534.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative efficacy and therapeutic positioning of biologics in hidradenitis suppurativa: A systematic review with network meta-analysis of randomised trials Document link: https://ijdvl.com/view-pdf/?article=a7bd6044d869344e54a82205ee8597e70OL9hrfXiOgycw== Document source: Indian Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148671/pdf/cureus-0016-00000061547.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review Document link: https://journals.sagepub.com/doi/epub/10.1177/12034754241260023 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18110 Document source: Alimentary Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: The efficacy and safety of different Janus kinase inhibitors as monotherapy in rheumatoid arthritis: A Bayesian network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11192398/pdf/pone.0305621.pdf Document source: PLoS One Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11258201/pdf/HSR2-7-e2210.pdf Document source: Health Science Reports Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparison of adalimumab with methotrexate for psoriasis: A meta-analysis of randomized controlled studies Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315506/pdf/medi-103-e37216.pdf Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Simlandi (adalimumab-ryvk) Prescribing Information. Document link: https://www.simlandihcp.com/globalassets/simlandihcp/prescribing-information.pdf Document source: Teva Pharmaceuticals, Parsippany, NJ Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Document link: https://ard.bmj.com/content/annrheumdis/82/1/3.full.pdf?with-ds=yes Document source: Annals of the Rheumatic Diseases Document type: Clinical Practice Guidelines Document year: 2023

Document title: Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication Document link: https://academic.oup.com/mr/article-pdf/33/1/21/49137216/roac017.pdf Document source: Modern Rheumatology Document type: Clinical Practice Guidelines Document year: 2023

Document title: An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621919/pdf/pone.0293655.pdf Document source: PLoS One Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442954/pdf/fphar-14-1237234.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2023.2249145?needAccess=true Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277136/pdf/bmjophth-2023-001303.pdf Document source: BMJ Open Ophthalmology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125768/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systematic review of clinical practice guidelines for uveitis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827242/pdf/bmjophth-2022-001091.pdf Document source: BMJ Open Ophthalmology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparison of Effectiveness and Safety of Ustekinumab and Adalimumab As Induction or Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226155/pdf/cureus-0015-00000038277.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226205/pdf/12886_2023_Article_2987.pdf Document source: JAMA Netw Open Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224469/pdf/pharmaceutics-15-01351.pdf Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220520/?report=printable Document source: JAMA Network Open Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology Document link: https://www.dldjournalonline.com/action/showPdf?pii=S1590-8658%2823%2900484-X Document source: Digestive and Liver Disease Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany Document link: https://www.tandfonline.com/doi/epdf/10.1080/03007995.2023.2214046?needAccess=true Document source: Current Medical Research and Opinion Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naive Patients with Moderate-to-Severe Ulcerative Colitis in Japan Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085930/pdf/40273_2023_Article_1254.pdf Document source: Pharmacoeconomics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951426/pdf/12969_2023_Article_798.pdf Document source: Pediatric Rheumatology Online Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative efficacy of advanced treatments in biologic-naive or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147762/pdf/11096_2022_Article_1509.pdf Document source: International Journal of Clinical Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis Document link: https://eprints.whiterose.ac.uk/190295/3/gutjnl-2022-328052R1%20CLEAN.pdf Document source: Gut Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Document link: https://academic.oup.com/ibdjournal/article-pdf/29/3/367/52523915/izac103.pdf Document source: Inflammatory Bowel Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1743811 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1744505?needAccess=true Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics and small molecules in patients with scalp psoriasis: a systematic review Document link: https://pubmed.ncbi.nlm.nih.gov/32406275 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1793891?needAccess=true Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2021.1892024?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629940/pdf/annrheumdis-2016-210459.pdf Document source: Modern Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies Document link: https://www.cghjournal.org/action/showPdf?pii=S1542-3565%2821%2900347-5 Document source: Clinical Gastroenterology and Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850822/pdf/cm9-135-011.pdf Document source: Chinese Medical Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913445/pdf/10067_2022_Article_6062.pdf Document source: Clinical Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798365/pdf/dic-2021-9-6.pdf Document source: Drugs in Context Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: The Risk of Adverse Effects of TNF-alpha Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888889/pdf/fimmu-13-814429.pdf Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402894/pdf/fphar-13-927179.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921985/pdf/fimmu-13-847160.pdf Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943739/pdf/rmdopen-2021-002074.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952692/pdf/jpm-12-00353.pdf Document source: Journal of personalized medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148207/pdf/ptt-12-99.pdf Document source: Medicine (Baltimore) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Adalimumab Effect on Pain in Hidradenitis Suppurativa Patients: Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116545/pdf/dp1202a99.pdf Document source: Lancet Gastroenterol Hepatol Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics and Small Molecule Inhibitors for Treating Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220298/pdf/biomedicines-10-01303.pdf Document source: Biomedicines Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357587/pdf/13555_2022_Article_760.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254215/pdf/WJCC-10-6091.pdf Document source: World Journal of Clinical Cases Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523983/pdf/40001_2022_Article_817.pdf Document source: European Journal of Medical Research Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562090/pdf/CD013818.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675210/pdf/12884_2022_Article_5191.pdf Document source: Gut Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and Safety of Anti-TNFalpha Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217376/pdf/40744_2021_Article_296.pdf Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials Document link: https://www.jidonline.org/action/showPdf?pii=S0022-202X%2821%2901149-0 Document source: The Journal of investigative dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080031/pdf/fphar-12-655865.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933137/pdf/nihms-1787830.pdf Document source: The Lancet. Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of the efficacy and safety indicators of DMARDs for rheumatoid arthritis: A network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294891/pdf/medi-100-e26524.pdf Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109175/pdf/fphar-12-673984.pdf Document source: Pharmacoeconomics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of adalimumab in hidradenitis suppurativa: A systematic review and meta-analysis of randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183777/pdf/medi-100-e26190.pdf Document source: BioDrugs Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials Document link: https://pubmed.ncbi.nlm.nih.gov/34281633 Document source: International Journal of Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Model-Based Meta-Analysis Compares DAS28 Rheumatoid Arthritis Treatment Effects and Suggests an Expedited Trial Design for Early Clinical Development Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894503/pdf/CPT-109-517.pdf Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review Document link: https://academic.oup.com/ecco-jcc/article/15/5/840/5904280?login=false Document source: Journal of Crohn's & Colitis Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991039/pdf/40744_2020_Article_259.pdf Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis Document link: https://www.tandfonline.com/doi/epdf/10.1080/1744666X.2020.1858803?needAccess=true Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391184/pdf/jmcp.2021.27.1.084.pdf Document source: Journal of Managed care & Specialty Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis Document link: https://www.tandfonline.com/doi/epdf/10.1080/17474124.2021.1880319?needAccess=true Document source: Expert Review of Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis Document link: https://www.jrheum.org/content/jrheum/47/1/59.full.pdf Document source: The Journal of Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials Document link: https://pubmed.ncbi.nlm.nih.gov/32483919 Document source: International Journal of Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: The effects of selected biologics and a small molecule on Health-Related Quality of Life in adult plaque psoriasis patients: A systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714099/pdf/pone.0241604.pdf Document source: PLoS One Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Safety and efficacy of newer biologics DMARDs in the management of rheumatoid arthritis: A systematic review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718147/pdf/main.pdf Document source: Osteoarthritis and Cartilage Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017220302407?via%3Dihub Document source: Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review Document link: https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.2311 Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis Document link: https://www.jdsjournal.com/action/showPdf?pii=S0923-1811%2820%2930199-7 Document source: Journal of Dermatological Science Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis Document link: https://pubmed.ncbi.nlm.nih.gov/32588642 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis Document link: https://academic.oup.com/bjd/article-lookup/doi/10.1111/bjd.19325 Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: The benefit-risk balance for biological agents in juvenile idiopathic arthritis: a meta-analysis of randomized clinical trials Document link: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/keaa170 Document source: Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naive to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32371431/ Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of anti-TNFalpha drugs in patients with stricturing Crohn's disease Document link: https://pubmed.ncbi.nlm.nih.gov/32351139 Document source: Expert Review of Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative efficacy and safety of 100 mg and 200 mg filgotinib administered to patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials Document link: https://pubmed.ncbi.nlm.nih.gov/32301699 Document source: International Journal of Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32206624/ Document source: Pediatric Gastroenterology, Hepatology & Nutrition Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286044/pdf/annrheumdis-2019-216656.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn's disease patients with perianal lesions: a systematic review Document link: https://air.unimi.it/retrieve/dfa8b9a1-6656-748b-e053-3a05fe0a3a96/PDF_Proof.PDF Document source: Expert Opinion on Biological Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006886/pdf/CPT-107-435.pdf Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318582/pdf/JDV-34-1050.pdf Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis Document link: https://pubmed.ncbi.nlm.nih.gov/31672037 Document source: The Annals of Pharmacotherapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic therapy for Behcet's uveitis: a systematic review Document link: https://pubmed.ncbi.nlm.nih.gov/31676596 Document source: British Journal of Ophthalmology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials Document link: https://pubmed.ncbi.nlm.nih.gov/31781849 Document source: Zeitschrift fur Rheumatologie Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011651/pdf/nihms-1680859.pdf Document source: Clinical Gastroenterology and Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933315-8 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956468/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis Document link: https://www.tandfonline.com/doi/epdf/10.1080/03007995.2020.1716701?needAccess=true Document source: Current Medical Research and Opinion Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31945470/ Document source: Clinical Gastroenterology and Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review Document link: https://pubmed.ncbi.nlm.nih.gov/31950853 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A cost per responder analysis of secukinumab vs adalimumab for the treatment of ankylosing spondylitis from the Korean perspective Document link: https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.13635 Document source: International Journal of Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis Document link: https://pubmed.ncbi.nlm.nih.gov/31272807 Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894001/pdf/10.1177_2050640619883566.pdf Document source: United European Gastroenterology Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: The Efficacy and Evidence-Based Use of Biologics in Children and Adolescents: Using Monoclonal Antibodies and Fusion Proteins as Treatments Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31711560/ Document source: Deutsches Arzteblatt International Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31617856/ Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758589/pdf/kez030.pdf Document source: Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis-A Network Meta-Analysis of 36 Randomized Controlled Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770755/pdf/ijms-20-04350.pdf Document source: International Journal of Molecular Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Treatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S1567576919312445?via%3Dihub Document source: International Immunopharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

• Indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Document title: Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review Document link: https://journals.sagepub.com/doi/full/10.1177/12034754241260023?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Bimzelx (bimekizumab-bkzx) Prescribing Information. Document link: https://www.ucb.com/sites/default/files/2023-11/master_bimzelx_10172023_en_USA.pdf Document source: UCB Inc., Smyrna, GA Document type: Product Monograph / Prescribing Information Document year: 2023

Document title: Efficacy and safety of bimekizumab for the treatment of psoriasis: a systematic review and meta-analysis of randomized clinical trials Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2023.2199106?needAccess=true Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany Document link: https://www.tandfonline.com/doi/epdf/10.1080/03007995.2023.2214046?needAccess=true Document source: Current Medical Research and Opinion Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.16691 Document source: The Journal of Dermatology Document type: Clinical Practice Guidelines Document year: 2022

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011535.pub6/full Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357587/ Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408312/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ddg.14308 Document source: Journal of the German Society of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956468/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

• Indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Document title: Safety and efficacy of Deucravacitinib for moderate to severe plaque psoriasis: A meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11344170/pdf/SRT-30-e13855.pdf Document source: Skin Research and Technology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative efficacy and safety of JAK/TYK2 inhibitors and other oral drugs for moderate-to-severe plaque psoriasis: Systematic review and network meta-analysis Document link: https://ijdvl.com/comparative-efficacy-and-safety-of-jak-tyk2-inhibitors-and-other-oral-drugs-for-moderate-to-severe-plaque-psoriasis-a-systematic-review-and-network-meta-analysis/ Document source: Indian Journal of Dermatology, Venereology and Teprology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272578/pdf/fimmu-14-1180170.pdf Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: The efficacy and safety of tyrosine kinase 2 inhibitor deucravacitinib in the treatment of plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570425/pdf/fmed-10-1264667.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Sotyktu (deucravacitinib) Prescribing Information. Document link: https://packageinserts.bms.com/pi/pi_sotyktu.pdf Document source: Bristol-Myers Squibb Company Princeton, NJ Document type: Product Monograph / Prescribing Information Document year: 2022

• Indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and weighing at least 40 kg.

Document title: Spevigo(R) (Spesolimab-Sbzo) Injection for the Treatment of Generalized Pustular Psoriasis Document link: https://pubmed.ncbi.nlm.nih.gov/39089999/ Document source: Skinmed Document type: Randomized Controlled Trials Document year: 2024

Document title: Spevigo (spesolimab-sbzo) Prescribing Information. Document link: https://content.boehringer-ingelheim.com/DAM/18918a08-b1a0-44f0-8f01-af1e01236719/spevigo-us-pi.pdf Document source: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil 1 study Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092680/pdf/JDE-50-183.pdf Document source: The Journal of Dermatology Document type: Randomized Controlled Trials Document year: 2023

Document title: Spesolimab improves patient-reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.18820 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Randomized Controlled Trials Document year: 2023

Document title: Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2823%2900350-X Document source: Journal of the American Academy Dermatology Document type: Randomized Controlled Trials Document year: 2023

Document title: Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial Document link: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01378-8/abstract Document source: The Lancet Document type: Randomized Controlled Trials Document year: 2023

Document title: Trial of Spesolimab for Generalized Pustular Psoriasis Document link: https://www.nejm.org/doi/10.1056/NEJMoa2111563?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: The New England Journal of Medicine Document type: Randomized Controlled Trials Document year: 2021

• Indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
• Indicated for the treatment of active psoriatic arthritis in adults
• Indicated for the treatment of moderately to severely active Crohn's disease in adults
• Indicated for the treatment of moderately to severely active ulcerative colitis in adults.

Document title: Comparative Effectiveness of Bimekizumab in Psoriatic Arthritis: A Model-Based Meta-Analysis of American College of Rheumatology Response Criteria Document link: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.3135 Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11190018/pdf/40265_2024_Article_2028.pdf Document source: Drugs Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative efficacy and therapeutic positioning of biologics in hidradenitis suppurativa: A systematic review with network meta-analysis of randomised trials Document link: https://ijdvl.com/comparative-efficacy-and-therapeutic-positioning-of-biologics-in-hidradenitis-suppurativa-a-systematic-review-with-network-meta-analysis-of-randomised-trials/ Document source: Indian Journal of Dermatology, Venereology and Leprology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11103324/pdf/ard-2024-225534.pdf Document source: Annals of the Rheumatic Diseases Document type: Clinical Practice Guidelines Document year: 2024

Document title: Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10868000/pdf/13075_2024_Article_3282.pdf Document source: Arthritis Research & Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and Safety of Risankizumab in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10920559/pdf/40744_2024_Article_638.pdf Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Skyrizi (risankizumab-rzaa) Prescribing Information. Document link: https://www.rxabbvie.com/pdf/skyrizi_pi.pdf Document source: AbbVie Inc., North Chicago, IL Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany Document link: https://www.tandfonline.com/doi/epdf/10.1080/03007995.2023.2214046?needAccess=true Document source: Current Medical Research and Opinion Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden Document link: https://www.tandfonline.com/doi/epdf/10.1080/13696998.2023.2259609?needAccess=true Document source: Journal of Medical Economics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety of IL-23 inhibitors in the treatment of psoriatic arthritis: a meta-analysis based on randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425519/pdf/12026_2023_Article_9366.pdf Document source: Immunologic Research Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070072/pdf/keac500.pdf Document source: Rheumatology (Oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: The Efficacy and Safety of Biologic Drugs in the Treatment of Moderate-Severe Crohn's Disease: A Systematic Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674451/pdf/pharmaceuticals-16-01581.pdf Document source: Pharmaceuticals (Basel, Switzerland) Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Safety and Efficacy of Risankizumab in Crohn's Disease: Prospective Real-World Experience and Systematic Literature Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910449/pdf/GH_19_12_supp8_11.pdf Document source: Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn's Disease: Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981469/pdf/nihms-1966325.pdf Document source: Digestive Diseases and Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Adverse Effects of Anti-Interleukin-23 Agents Employed in Patients with Psoriasis: A Systematic Review Document link: https://karger.com/drm/article/238/5/886/823440/Adverse-Effects-of-Anti-Interleukin-23-Agents Document source: Dermatology (Basel, Switzerland) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357587/pdf/13555_2022_Article_760.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: A Systematic Review with Meta-Analysis of Comparative Efficacy and Safety of Risankizumab and Ustekinumab for Psoriasis Treatment Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410857/pdf/JIR2022-2802892.pdf Document source: Journal of Immunology Research Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011535.pub5/full#0 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics. Document link: https://www.minervamedica.it/en/getfreepdf/RkppUTZneThOZUxDMjNHN2xmMGhNTkkxVjBndXMrcXBtcEl5UFdBZGd5RXI4bThVWUFZWG1FWTRTaFVPYmg5WQ%253D%253D/R23Y2022N06A0469.pdf Document source: Italian Journal of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2022

Document title: An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1744505?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1743811?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056462/pdf/12325_2022_Article_2065.pdf Document source: Advances in Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values

Document title: Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391184/pdf/jmcp.2021.27.1.084.pdf Document source:  Journal of Managed Care & Specialty Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2821%2900422-9 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995584/pdf/12969_2021_Article_514.pdf Document source: Pediatric Rheumatology Online Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408312/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611163/pdf/13555_2021_Article_602.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933137/pdf/nihms-1787830.pdf Document source: The Lancet Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042876/?report=printable Document source: JAMA Dermatology (Chicago, Ill.) Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis Document link: https://www.jdsjournal.com/action/showPdf?pii=S0923-1811%2820%2930199-7 Document source:  Journal of Dermatological Science Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/dth.13802 Document source: Dermatologic Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956468/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis Document link: https://journals.sagepub.com/doi/10.1177/1060028019885836?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: The Annals of Pharmacotherapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006886/pdf/CPT-107-435.pdf Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Response to Placebo, Measured by Endoscopic Evaluation of Crohn's Disease Activity, in a Pooled Analysis of Data From 5 Randomized Controlled Induction Trials Document link: https://www.cghjournal.org/action/showPdf?pii=S1542-3565%2819%2930900-0 Document source: Clinical Gastroenterology and Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Japanese guidance for use of biologics for psoriasis (the 2019 version). Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.15196 Document source: The Journal of Dermatology Document type: Clinical Practice Guidelines Document year: 2020

• Indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Document title: Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11190018/pdf/40265_2024_Article_2028.pdf Document source: Drugs Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Ilumya (tildrakizumab-asmn) Prescribing Information. Document link: https://www.ilumya.com/Sun_Pharma_ILUMYA_US_Prescribing_Information_%20(2).pdf Document source: Sun Pharmaceutical Industries, Inc., Princeton, NJ Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris - part 1: treatment and monitoring recommendations. Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16915 Document source: Journal of the European Academy of Dermatology and Venerology Document type: Clinical Practice Guidelines Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056462/pdf/12325_2022_Article_2065.pdf Document source: Advances in Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics Document link: https://www.minervamedica.it/en/getfreepdf/cjhFVTVWNG9DakdyNTFrbkZvWHhNc2hqajRZOTY3b2J0bThOcHZBZDFBVWtrMEFJaGpaSm5pOHJvcTIrNmhGYQ%253D%253D/R23Y2022N06A0469.pdf Document source: Italian Journal of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2022

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943739/pdf/rmdopen-2021-002074.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125768/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Adverse Effects of Anti-Interleukin-23 Agents Employed in Patients with Psoriasis: A Systematic Review Document link: https://karger.com/drm/article/238/5/886/823440/Adverse-Effects-of-Anti-Interleukin-23-Agents Document source: Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis Document link: https://onlinelibrary.wiley.com/doi/10.1111/ddg.14308 Document source: Journal of the German Society of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2821%2900422-9 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995584/pdf/12969_2021_Article_514.pdf Document source: Pediatric Rheumatology Online Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis Document link: https://journals.sagepub.com/doi/10.1177/1060028019885836?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: The Annals of Pharmacotherapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.15920 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064936/pdf/BJD-182-605.pdf Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A Systematic Literature Review and Bucher Indirect Comparison: Tildrakizumab versus Guselkumab Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398610/pdf/jheor-7-2-13671.pdf Document source: Journal of Health Economics and Outcomes Research Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis Document link: https://academic.oup.com/bjd/article-abstract/183/4/638/6761593?redirectedFrom=fulltext&login=false Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis Document link: https://onlinelibrary.wiley.com/doi/10.1111/dth.13802 Document source: Dermatologic Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956468/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

• Indicated for the treatment of patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
• Indicated for the treatment of adults with active psoriatic arthritis
• Indicated for the treatment of adults with active ankylosing spondylitis
• Indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

Document title: 2023 guidelines on the management of psoriasis by the Dermatological Society of Singapore Document link: https://annals.edu.sg/2023-guidelines-on-the-management-of-psoriasis-by-the-dermatological-society-of-singapore/ Document source: Annals of the Academy of Medicine, Singapore Document type: Clinical Practice Guidelines Document year: 2024

Document title: Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review Document link: https://journals.sagepub.com/doi/epub/10.1177/12034754241260023 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11190018/pdf/40265_2024_Article_2028.pdf Document source: Drugs Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Effects of secukinumab and ixekizumab on major adverse cardiovascular events in patients with psoriasis: a meta-analysis of randomized controlled trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10951107/pdf/fmed-11-1353893.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11065447/pdf/kead598.pdf Document source: Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11103324/pdf/ard-2024-225534.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Taltz (ixekizumab) Prescribing Information. Document link: https://uspl.lilly.com/taltz/taltz.html#pi Document source: Eli Lilly and Company, Indianapolis, IN Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Assessing Comparative Efficacy of Biologics for the Treatment of Psoriasis With Nail Involvement: A Systematic Review Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11361496/pdf/10.1177_24755303231217491.pdf Document source: Journal of Psoriasis and Psoriatic Arthritis Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: The Impact of Interleukin-17 Inhibitors on Major Adverse Cardiovascular Events in Psoriasis or Psoriatic Arthritis Patients Naive to Biologic Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11193915/pdf/cureus-0016-00000060980.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10011375/pdf/40744_2022_Article_522.pdf Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: The Efficacy and Safety of Subcutaneous Ixekizumab for the Treatment of Axial Spondylarthritis: A Systematic Review and Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10039670/pdf/cureus-0015-00000035360.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis Document link: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.24630 Document source: Arthritis Care & Research Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Gastroenterological safety of IL-17 inhibitors: a systematic literature review Document link: https://www.tandfonline.com/doi/full/10.1080/14740338.2021.1960981 Document source: Expert Opinion on Drug Safety Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9056462/pdf/12325_2022_Article_2065.pdf Document source: Advances in Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8943739/pdf/rmdopen-2021-002074.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9017712/pdf/fphar-13-847308.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9357587/pdf/13555_2022_Article_760.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9608970/pdf/pharmaceutics-14-02140.pdf Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1743811?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1836313 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics Document link: https://www.minervamedica.it/en/getfreepdf/Mi9JaXpjRUFHa0QzRHRncGErU0FZV2JPa3hnVG1QOFgyNEFyS0I3aEpmSGVCMk4rZHVyaEhRMDVYbDdkaEJOUA%253D%253D/R23Y2022N06A0469.pdf Document source: Italian Journal of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2022

Document title: Biologics and small molecules in patients with scalp psoriasis: a systematic review Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1770167 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparison of guidelines for the use of interleukin-17 inhibitors for psoriasis in the United States, Britain, and Europe: a critical appraisal and comprehensive review. Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8594534/pdf/jcad_14_6_55.pdf Document source: Journal of Clinical and Aesthetic Dermatology Document type: Clinical Practice Guidelines Document year: 2021

Document title: A systematic review of treatment strategies for erythrodermic psoriasis Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2019.1689228 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of interleukin-17 inhibitors in the treatment of chronic rheumatic diseases: A combined and updated meta-analysis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcpt.13416 Document source: Journal of Clinical Pharmacy and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Review of treatments for generalized pustular psoriasis Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2019.1682502 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy of a second interleukin 17 inhibitor in patients with psoriasis: A systematic review and meta-analysis Document link: https://www.jaad.org/article/S0190-9622(20)32286-6/abstract Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis Document link: https://onlinelibrary.wiley.com/doi/10.1111/ddg.14308 Document source: Journal der Deutschen Dermatologischen Gesellschaft Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8289786/pdf/10067_2020_Article_5545.pdf Document source: Clinical Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of secukinumab, ixekizumab, and tofacitinib in patients with active psoriatic arthritis showing insufficient response to tumor necrosis factor inhibitors Document link: https://www.dustri.com/nc/article-response-page.html?artId=187857&doi= Document source: International Journal of Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review Document link: https://onlinelibrary.wiley.com/doi/10.1111/dth.14889 Document source: Dermatologic Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8611163/pdf/13555_2021_Article_602.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of secukinumab and ixekizumab in patients with active ankylosing spondylitis Document link: https://link.springer.com/article/10.1007/s00393-020-00837-9 Document source: Zeitschrift fur Rheumatologie Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of Efficacy of Anti-interleukin-17 in the Treatment of Psoriasis Between Caucasians and Asians: A Systematic Review and Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8822240/pdf/fmed-08-814938.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values

Document title: EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: treatment and monitoring recommendations Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16915 Document source: Journal of the European Academy of Dermatology and Venerology Document type: Clinical Practice Guidelines Document year: 2020

Document title: Japanese guidance for use of biologics for psoriasis (the 2019 version) Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.15196 Document source: Journal of Dermatology Document type: Clinical Practice Guidelines Document year: 2020

Document title: Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis Document link: https://www.jrheum.org/content/jrheum/47/1/59.full.pdf Document source: The Journal of Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7216398/pdf/13075_2020_Article_2208.pdf Document source: Arthritis Research & Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis Document link: https://onlinelibrary.wiley.com/doi/10.1111/jcpt.13153 Document source: Journal of Clinical Pharmacy and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7733711/pdf/keaa189.pdf Document source: Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis Document link: https://academic.oup.com/bjd/article-abstract/183/4/638/6761593?redirectedFrom=fulltext&login=false Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis Document link: https://journals.sagepub.com/doi/10.1177/1203475420933174?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis Document link: https://www.jdsjournal.com/action/showPdf?pii=S0923-1811%2820%2930199-7 Document source: Journal of Dermatological Science Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review Document link: https://journals.sagepub.com/doi/10.1177/1203475419897578?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes Document link: https://www.clinexprheumatol.org/abstract.asp?a=14325 Document source: Clinical and Experimental Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.16246 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Risk of tuberculosis reactivation during interleukin-17 inhibitor therapy for psoriasis: a systematic review Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.16254 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7042876/ Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7046955/pdf/rmdopen-2019-001117.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://ard.bmj.com/content/79/6/778.long Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: The effects of selected biologics and a small molecule on Health-Related Quality of Life in adult plaque psoriasis patients: A systematic review and meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7714099/pdf/pone.0241604.pdf Document source: PLoS One Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7843938/pdf/fmed-07-618163.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic Drug Survival in Psoriasis: A Systematic Review & Comparative Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8012481/pdf/fmed-07-625755.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.15920 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biological therapy for pustular psoriasis: a systematic review Document link: https://onlinelibrary.wiley.com/doi/10.1111/ijd.14671 Document source: International Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic therapies targeting the interleukin (IL)-23/IL-17 immune axis for the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.15879 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Adverse events with IL-17 and IL-23 inhibitors for psoriasis and psoriatic arthritis: a systematic review and meta-analysis of phase III studies Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.16073 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://www.jaad.org/article/S0190-9622(19)33315-8/fulltext Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017219300447?via%3Dihub Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

• Indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies.

Document title: Assessing Comparative Efficacy of Biologics for the Treatment of Psoriasis With Nail Involvement: A Systematic Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361496/pdf/10.1177_24755303231217491.pdf Document source: Journal of Psoriasis and Psoriatic Arthritis Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11190018/pdf/40265_2024_Article_2028.pdf Document source: Drugs Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Siliq (brodalumab) Prescribing Information. Document link: https://pi.bauschhealth.com/globalassets/BHC/PI/Siliq-pi.pdf Document source: Bausch Health US, LLC., Bridgewater, NJ Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics. Document link: https://www.minervamedica.it/en/freedownload.php?cod=R23Y2022N06A0469 Document source: Italian Journal of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2022

Document title: Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2021.1892024?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574679/pdf/ActaDV-102-1993.pdf Document source: Acta Dermato-Venereologica Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943739/pdf/rmdopen-2021-002074.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1743811?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparison of Efficacy of Anti-interleukin-17 in the Treatment of Psoriasis Between Caucasians and Asians: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822240/pdf/fmed-08-814938.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values

Document title: Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611163/pdf/13555_2021_Article_602.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042876/?report=printable Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933315-8 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Japanese guidance for use of biologics for psoriasis (the 2019 version) Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.15196 Document source: The Journal of Dermatology Document type: Clinical Practice Guidelines Document year: 2020

Document title: Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcpt.13153 Document source: Journal of Clinical Pharmacy and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis Document link: https://journals.sagepub.com/doi/10.1177/1203475420933174?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

• Indicated for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
• Indicated for the treatment of adult patients of active psoriatic arthritis.

Document title: Tremfya (guselkumab) Prescribing Information. Document link: https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/TREMFYA-pi.pdf Document source: Janssen Biotech, Inc., Horsham, PA Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11103324/pdf/ard-2024-225534.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10868000/pdf/13075_2024_Article_3282.pdf Document source: Arthritis Research & Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: A systematic review of recent randomized controlled trials for palmoplantar pustulosis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2024.2414048?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis Document link: https://link.springer.com/article/10.1007/s40257-024-00849-0 Document source: American Journal of Clinical Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety of IL-23 inhibitors in the treatment of psoriatic arthritis: a meta-analysis based on randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425519/pdf/12026_2023_Article_9366.pdf Document source: Immunologic Research Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070072/pdf/keac500.pdf Document source: Rheumatology (Oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125768/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1743811?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1793891?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2021.1892024?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056462/pdf/12325_2022_Article_2065.pdf Document source: Advances in Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943739/pdf/rmdopen-2021-002074.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Adverse Effects of Anti-Interleukin-23 Agents Employed in Patients with Psoriasis: A Systematic Review Document link: https://karger.com/drm/article/238/5/886/823440/Adverse-Effects-of-Anti-Interleukin-23-Agents Document source: Dermatology (Basel, Switzerland) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics. Document link: https://www.minervamedica.it/en/freedownload.php?cod=R23Y2022N06A0469 Document source: Italian Journal of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2022

Document title: Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2821%2900422-9 Document source:  Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values

Document title: Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391184/pdf/jmcp.2021.27.1.084.pdf Document source: Journal of Managed Care & Specialty Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Relative efficacy and safety of secukinumab and guselkumab for the treatment of active psoriatic arthritis: A network meta-analysis Document link: https://www.dustri.com/nc/article-response-page.html?artId=187910&doi= Document source: International Journal of Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611163/pdf/13555_2021_Article_602.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408312/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995584/pdf/12969_2021_Article_514.pdf Document source: Pediatric Rheumatology Online Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121447/pdf/keab119.pdf Document source: Rheumatology (Oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042876/?report=printable Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Interventions for chronic palmoplantar pustulosis Document link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011628.pub2/full#0 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Japanese guidance for use of biologics for psoriasis (the 2019 version) Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.15196 Document source: The Journal of Dermatology Document type: Clinical Practice Guidelines Document year: 2020

Document title: Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate-to-severe plaque psoriasis: the COMPASS analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496582/pdf/BJD-183-276.pdf Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011535.pub3/full#0 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933315-8 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Assessing the Short-Term Efficacy and Safety of Guselkumab for Moderate-to-Severe Plaque Psoriasis: Meta-Analysis of Randomized Controlled Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382754/pdf/JIR2020-4975628.pdf Document source: Journal of Immunology Research Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A Systematic Literature Review and Bucher Indirect Comparison: Tildrakizumab versus Guselkumab Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398610/pdf/jheor-7-2-13671.pdf Document source: Journal of Health Economics and Outcomes Research Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis Document link: https://onlinelibrary.wiley.com/doi/10.1111/dth.13802 Document source: Dermatologic Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286044/pdf/annrheumdis-2019-216656.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://ard.bmj.com/content/79/6/778.long# Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

• Indicated for the treatment of moderate to severe plaque psoriasis (PsO) in patients 6 years and older who are candidates for systemic therapy or phototherapy
• Indicated for the treatment of active psoriatic arthritis (PsA) in patients 2 years of age and older
• Indicated for the treatment of adults with active ankylosing spondylitis (AS)
• Indicated for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation
• Indicated for the treatment of active enthesitis-related arthritis (ERA) in patients 4 years of age and older.

Document title: Assessing the 5-year persistence in positive clinical response with innovative psoriasis treatments: a network meta-analysis of Psoriasis Area and Severity Index score Document link: https://academic.oup.com/ced/article-abstract/49/10/1148/7645633?redirectedFrom=fulltext&login=false Document source: Clinical and Experimental Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11190018/pdf/40265_2024_Article_2028.pdf Document source: Drugs Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review Document link: https://journals.sagepub.com/doi/epub/10.1177/12034754241260023 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: The Impact of Interleukin-17 Inhibitors on Major Adverse Cardiovascular Events in Psoriasis or Psoriatic Arthritis Patients Naive to Biologic Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11193915/pdf/cureus-0016-00000060980.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of drugs for psoriasis patients with mental disorders: A systematic review Document link: https://www.sciencedirect.com/science/article/abs/pii/S0165032724012904?via%3Dihub Document source: Journal of Affective Disorders Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Clinical efficacy and safety of secukinumab in the treatment of generalized pustular psoriasis in the pediatric population: a systematic review of the literature Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11341497/pdf/fmed-11-1377381.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: A systematic review of recent randomized controlled trials for palmoplantar pustulosis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2024.2414048?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative efficacy and therapeutic positioning of biologics in hidradenitis suppurativa: A systematic review with network meta-analysis of randomised trials Document link: https://ijdvl.com/view-pdf/?article=2527a0d2881d9cc31e84b88cfab5d297DcSXJvC/kjHLSQ== Document source: Indian Journal of Dermatology, Venereology and Leprology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Impact of treatments on fatigue in axial spondyloarthritis: a systematic review and meta-analysis Document link: https://academic.oup.com/rheumatology/advance-article-abstract/doi/10.1093/rheumatology/keae549/7817830?redirectedFrom=fulltext&login=false Document source: Rheumatology (Oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11065447/pdf/kead598.pdf Document source: Rheumatology (Oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and Safety of Secukinumab for the Treatment of Psoriasis: A Meta-Analysis of Pivotal Phase III Trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11065447/pdf/kead598.pdf Document source: Dermatology (Basel, Switzerland) Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative Effectiveness of Bimekizumab in Psoriatic Arthritis: A Model-Based Meta-Analysis of American College of Rheumatology Response Criteria Document link: https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/cpt.3135 Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Bony proliferations in rheumatoid arthritis, psoriatic arthritis and osteoarthritis using high-resolution peripheral quantitative computed tomography-A systematic literature review Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1756-185X.15068 Document source: International Journal of Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: From PsO to PsA: the role of T(RM) and Tregs in psoriatic disease, a systematic review of the literature Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10884248/pdf/fmed-11-1346757.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy of anti-interleukin-17A biological agents for palmoplantar psoriasis and palmoplantar pustulosis: A network meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S1567576924002340?via%3Dihub Document source: International Immunopharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis Document link: https://link.springer.com/article/10.1007/s40257-024-00849-0 Document source: American Journal of Clinical Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Formation and clinical effects of anti-drug antibodies against biologics in psoriasis treatment: An analysis of current evidence Document link: https://www.sciencedirect.com/science/article/abs/pii/S1568997224000211?via%3Dihub Document source: Autoimmunity Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11103324/pdf/ard-2024-225534.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Effects of secukinumab and ixekizumab on major adverse cardiovascular events in patients with psoriasis: a meta-analysis of randomized controlled trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10951107/pdf/fmed-11-1353893.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysis Document link: https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-024-00361-3 Document source: Advances in Rheumatology (London, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Cosentyx (secukinumab) Prescribing Information. Document link: https://www.novartis.com/us-en/sites/novartis_us/files/cosentyx.pdf Document source: Novartis Pharmaceuticals Corporation, East Hanover, NJ Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Systematic review of TNFalpha-induced paradoxical psoriasis: Treatment outcomes of switching to alternative biologic therapies in inflammatory bowel disease patients Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2022.2133533?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijd.16064 Document source: International Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2022.2133533?needAccess=true Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10224469/pdf/pharmaceutics-15-01351.pdf Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review Document link: https://link.springer.com/article/10.1007/s40257-023-00786-4 Document source: American Journal of Clinical Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Non-anti TNFalpha biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review Document link: https://www.tandfonline.com/doi/full/10.1080/1744666X.2023.2193687 Document source: Expert Review of Clinical Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10002880/pdf/ijms-24-05006.pdf Document source: International Journal of Molecular Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10011375/pdf/40744_2022_Article_522.pdf Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase-4 inhibitors Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.18810 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand Document link: https://www.valuehealthregionalissues.com/action/showPdf?pii=S2212-1099%2822%2900192-3 Document source: Value in Health Regional Issues Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10711909/pdf/rmdopen-2023-003349.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: A Systematic Review and Meta-Analysis of Injection Site Reactions in Randomized-Controlled Trials of Biologic Injections Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10486173/pdf/10.1177_12034754231188444.pdf Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy of biologic agents for palmoplantar psoriasis: a systematic review and network meta-analysis Document link: https://tandfonline.com/doi/full/10.1080/1744666X.2023.2272049 Document source: Expert Review of Clinical Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017222000476?via%3Dihub Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9125768/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9608970/pdf/pharmaceutics-14-02140.pdf Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Real-life efficacy and drug continuation of secukinumab in treating moderate to severe plaque psoriasis in Aegean region of Turkey: a multicenter retrospective study and systematic review of the literature Document link: https://apjai-journal.org/wp-content/uploads/2022/10/AP-241021-1259.pdf Document source: Asian Pacific journal of Allergy and Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials Document link: https://www.dustri.com/nc/article-response-page.html?artId=188834&doi= Document source: International Journal of Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis Document link: https://karger.com/pha/article-pdf/107/11-12/537/3736899/000525627.pdf Document source: Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics for pediatric psoriasis: A systematic review and meta-analysis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/pde.14870 Document source: Pediatric Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8850822/pdf/cm9-135-011.pdf Document source: Chinese Medical Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9017712/pdf/fphar-13-847308.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9357587/pdf/13555_2022_Article_760.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8798365/pdf/dic-2021-9-6.pdf Document source: Drugs in Context Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Anti-drug antibodies of IL-17 inhibitors for psoriasis: a systematic review Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2022.2114288 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics for pediatric moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ddg.14832 Document source: Journal of the German Society of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9148207/pdf/ptt-12-99.pdf Document source: Psoriasis (Auckland, N.Z.) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021 Document link: https://www.nature.com/articles/s41584-022-00798-0 Document source: Nature Reviews Rheumatology Document type: Clinical Practice Guidelines Document year: 2022

Document title: Practical update of the guidelines published by the psoriasis group of the Spanish academy of dermatology and venereology (GPs) on the treatment of psoriasis with biologic agents: part 2----management of special populations, patients with comorbid conditions, and risk Document link: https://pdf.sciencedirectassets.com/277731/1-s2.0-S0001731022X00082/1-s2.0-S000173102200415X/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEFsaCXVzLWVhc3QtMSJHMEUCIGEqpEpWoW8WjPCJjd1teJVsoFVO4BUat5%2FsEVn90lWZAiEAhJ7K9lBlFBdFyCgoDPWxnChm1emecoqJi7o8lxG2yvUquwUIw%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FARAFGgwwNTkwMDM1NDY4NjUiDBxgFMi69X4rQIB5kCqPBaa0jB61EXbsVNJ3gYuPqUZDB4AcxIJwfO10c3pybgwelgdIm5EL5ROuuvl20mt%2FrEhgRRGJmWmEne7FAYPSCw%2Fquv5%2FxlEZzvPlt%2FX9m5oRabQdBk%2BFeFNZ0QTssEXX6JsOQ9BBxX4074HGVjP3E6OiUAEFqlyf397UbN3AiPQ6EcNi915Mm5OTJS8mCBQboXOEVJxoTMKZ3CPcxBaXBULcbtZbdahMFmqx%2BaVaWNebXVqTP8Pn9NuocHJIL6mG%2FoxKZ3KFsD8tqVOWSooS5mdEMrlKzjoJFmba%2B0TsDdOU3plUrNLZ4WTkSGYFm1%2FWAmIEV6YXK%2Bp861FeFVnBlkmxdq%2BZahSJXgsv9gITddTIe%2FjYfALq1vJCK%2BCD1jXkGHTS%2F76qZpWHG1ei9uSDSVseV663%2Buode%2FMiqCG0UED6UP2OREmrnYQTZYbJidataq5VT1nSLwVNHm3n7jM1Suo%2F8aadvG761cwFJ%2BrNwveHh0s1bNbHjb8QVU6O%2FmLoBfcCxJRE8E9A80E6WshuRH5zMqYzGMro02e4P9plFrylGb7gGJeIVLmyfpjHlFd3sQy9qx7lgG8U27RCW0nApHZqkyOr45t6Bh4gbEL3p8OmVJlAl%2FhlpIKYyhwvNYIoLoaTu6%2BYFDuUCpUgYAkjkocFChZ10I4%2FPSH3nLgEu23yK6N1GVHAuVaNi21w%2B60zxx9kMb6sOZRZtnr3HYiYSNUDPns8rXbi0fNps8OrLX4Wsqw%2BM71M5TUEo5qjTZf4JDWyz5zELk0V8CyeGf%2FfE%2FEuSPrz1rXK2vgiiUnuCzL39XxkpbRl7b%2Bnob1NFE2c7wWD0rVOjuPi8lcgpWH4lnHzh81%2F5J4iOkqQ3Iy3DakwyPzkuAY6sQGAvWhuT2Z7HWrUn2hJ8W%2BzJsKmvypvPu71NNHA5HLmu3lW%2BoAsc3mikWFTa3p1RkFR6nz8OS%2B7cZ1lPM0wlfFxgmz4tbAIPvKye6UMc8cZQxNN9I5byHVRMjePd128FiTqLmCpHJSfLgX%2FERJI1scj9tZ5EvX0pdAd3JENNTl1hL9O4D7Qx2KR6nfDrXRPVbyfpL6b4cy%2FPXZESZ5c2jiGepcOKZctKhhFeIHlQ2K%2BBwk%3D&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Date=20241023T190730Z&X-Amz-SignedHeaders=host&X-Amz-Expires=300&X-Amz-Credential=ASIAQ3PHCVTYZUNHPMHJ%2F20241023%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Signature=61372ae7d5a71dbfdf1c78583547bd9fd222d61d4226299ae0ad4984b5b0d62a&hash=451082b5d3cc6c05d5b5c93609d2214461efa9e0cd6998618d06e7539b601238&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&pii=S000173102200415X&tid=spdf-48d3d569-bc42-483a-871c-fd6d3d70cace&sid=f4200e6869b6814ee8081ea7adc7e351548dgxrqa&type=client&tsoh=d3d3LnNjaWVuY2VkaXJlY3QuY29t&ua=05075b04505653500207&rr=8d7402aa1f1433fa&cc=ca Document source: Actas Dermo-Sifiliográficas Document type: Clinical Practice Guidelines Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1743811?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics and small molecules in patients with scalp psoriasis: a systematic review Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1770167 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1836313 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Gastroenterological safety of IL-17 inhibitors: a systematic literature review Document link: https://www.tandfonline.com/doi/full/10.1080/14740338.2021.1960981 Document source: Expert Opinion on Drug Safety Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Treatment Outcomes of IL-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review Document link: https://journals.sagepub.com/doi/epub/10.1177/12034754211035667 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8943739/pdf/rmdopen-2021-002074.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8611163/pdf/13555_2021_Article_602.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of secukinumab in patients with psoriatic arthritis: A meta-analysis of different dosing regimens Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8449858/pdf/cln-76-2820.pdf Document source: Clinics (Sao Paulo, Brazil) Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8322248/pdf/13555_2021_Article_559.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Review of treatments for generalized pustular psoriasis Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2019.1682502 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: A systematic review of treatment strategies for erythrodermic psoriasis Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2019.1689228 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of Efficacy of Anti-interleukin-17 in the Treatment of Psoriasis Between Caucasians and Asians: A Systematic Review and Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8822240/pdf/fmed-08-814938.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7995584/pdf/12969_2021_Article_514.pdf Document source: Pediatric Rheumatology Online Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Twelve-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post hoc analysis of six randomised trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7986672/pdf/JDV-35-928.pdf Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8289786/pdf/10067_2020_Article_5545.pdf Document source: Clinical Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Differences in biologics for treating ankylosing spondylitis: the contribution of network meta-analysis Document link: https://www.europeanreview.org/wp/wp-content/uploads/56-64.pdf Document source: European Review for Medical and Pharmacological Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Interventions for chronic palmoplantar pustulosis: abridged Cochrane systematic review and GRADE assessments Document link: https://academic.oup.com/bjd/article-abstract/184/6/1023/6697829?redirectedFrom=fulltext&login=false Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7952370/pdf/40259_2021_Article_467.pdf Document source: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/dth.14889 Document source: Dermatologic Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of interleukin-17 inhibitors in the treatment of chronic rheumatic diseases: A combined and updated meta-analysis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcpt.13416 Document source: Journal of Clinical Pharmacy and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Psoriatic onycho-pachydermo periostitis (POPP): a case report treated successfully with IL-17 blockade and a literature review on characteristics, pathogenesis, and treatment Document link: https://link.springer.com/article/10.1007/s10067-021-05729-0 Document source: Clinical Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8408312/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials Document link: https://www.jidonline.org/action/showPdf?pii=S0022-202X%2821%2901149-0 Document source: The Journal of Investigative Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Skin and soft tissue infections in biological therapy for psoriasis-A case report and systematic review of the literature Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/ijd.15679 Document source: International Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: 2021 clinical practice guideline for the early detection, diagnosis, treatment, and monitoring of patients with axial spondyloarthritis Document link: https://www.reumatologiaclinica.org/en-pdf-S2173574322000430 Document source: Reumatologia Clinica Document type: Clinical Practice Guidelines Document year: 2021

Document title: Indonesian clinical practice guidelines for systemic and biologic agents for adults with plaque psoriasis Document link: https://scholarhub.ui.ac.id/cgi/viewcontent.cgi?article=1102&context=jdvi Document source: Journal of General - Procedural Dermatology & Venereology Indonesia Document type: Clinical Practice Guidelines Document year: 2021

Document title: Short-Term Efficacy and Safety of Secukinumab for Ankylosing Spondylitis: A Systematic Review and Meta-Analysis of RCTs Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7641709/pdf/MI2020-1639016.pdf Document source: Mediators of Inflammation Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: The pharmacological and clinical aspects behind dose loading of biological disease modifying anti-rheumatic drugs (bDMARDs) in auto-immune rheumatic diseases (AIRDs): rationale and systematic narrative review of clinical evidence Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7385956/pdf/41927_2020_Article_130.pdf Document source: BMC Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7402795/pdf/medi-99-e21447.pdf Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Effect of biologics on radiographic progression of peripheral joint in patients with psoriatic arthritis: meta-analysis Document link: https://watermark.silverchair.com/keaa313.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA2kwggNlBgkqhkiG9w0BBwagggNWMIIDUgIBADCCA0sGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM-yIORjA3HnNCt9lUAgEQgIIDHJAP6jkNrsuirfJhqtrY_xcWzhSr6heIaJ4Dnv-2BDKkqusnIoTgq-CSnLaKL_Lomy3T40LNbum6_lii-OuEhKnedn9SiqpgW6fkxxmoZZnrfAwNoJHOT4Ww1JpOGPajvRWXNaav7-OO2os1Ao6l_UQk0w6-pX360KMgeoqpq1nHxwc-JsEM2covXtcP9NjaQbM2LCEVmgAFQpdG4dq9n3lXDQKAvc7dtbZOoY5Y-EK0_0lSqb2fx27BjRHpQzSFacF0rKGbBkzqEkv2kN9SXFJOO9TEbZ3zFa4SpWq1UgXL1ZK9qubjmv8vApX6pMq7YhKMBmIAjuUJHlveynKsufqCN3-KoSuC2M4h9dNfNfg-I101LsSOGGf6ees0DDyd5A6T8hW65NmrD6UGnJLk2I4n_89PGXIOyV04bIvLuDRqMQDI-hjY43T6llsEuwPVU3_nV4fAPUlBN5x-ZeJtvomdyeYBThyfAXE20Qxci9QXPnsDOlhI0a_tARCCyzvnikHbjJJVvp0sDCtMdcTaEFspyUBdnzAEOMqOuxSvCWaQcyQ1hba5FA6sFMxQ5P_6JEYPMHntyN4IbUFN3shBCTUYa-Y7XMHJ4Orqu1ALklfLkPzXJJt9srXsQv1vOn3ZtXSE4-83ByKBsWgSZzk8NiOy0QgCEq2cP071OpK0LfWwq0YOYRLaNDSnP5oI4jxpLFEnzMfUMwBeE1pdsHCsL0R4KypPaaqz_FMdRYqqOrVaqTPhETN0AoESHw0oP6_kWQFq4cU2lPCz3q3lzrc5FzTRzuv0ksWXoDDxPmwlmw1KZylgrulJSwvvmetVdf7rccy4rsdqE_s6SOMeDt9M5t-tLm0E3l5CZAVk69XgCCyIlYmpSBuK6vMTS-d0w6jpk6PF4QyrNPzYnMecCpv4ttYZQC57Sk2qyu--pNWiYBqayz2-CzpJJs80kjQA9F6hJzhzpUVifZK27lEOnbNuqMbXA-Ehe8XNMwIBudj5VEs2-37zOz_AgYYb_grT0hqWtb-yzRM59hgfpDmnb8NeSe6REHcjjeFW6FiZA8I Document source: Rheumatology (Oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review Document link: https://jamanetwork.com/journals/jamadermatology/article-abstract/2769110 Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence Document link: https://link.springer.com/article/10.1007/s40259-020-00442-x Document source: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and Safety of Anti-Interleukin-17A Monoclonal Antibody Secukinumab in Treatment of Ankylosing Spondylitis: A Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8420952/pdf/mab.2020.0022.pdf Document source: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Association of previous treatment with anti-tumour necrosis factor inhibitors with the effectiveness of secukinumab in the treatment of psoriatic arthritis: systematic review and meta-analysis Document link: https://watermark.silverchair.com/keaa449.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA2kwggNlBgkqhkiG9w0BBwagggNWMIIDUgIBADCCA0sGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMUXOsbGcT2XUD97LCAgEQgIIDHKe912OyiJ9crgPZLYjfZT96Q7nQvq3u0Om_8jYNH1lTvUJ2W7Yc0k2BVIIW9J3TcGV8Vt5s-2NLBUFeBaWr7AZ4ooBrQR-Py4BZY9JzEgvZFcBMHCwv-UJTuD8g8r416WxcgSFrUUOjRhpf2HxapZPCRsEfTIQ4SGBiARb9Iw-1LiwP11FTQWwp_4dSZTC1NwaiwExh4WH9ic6XHsQOAi1Rgn2HCc76v8xX0Zi0926tY4J5NXHYkhs2N69OPEgUHxNB1FdAHaHio8BlNM_y7LaiaBQZrpx0tdl4LvOI7whm9N3YEHiZGD2KaoapN64OR0_kxirfJAid4eLvbVnUNqrhiOBnfcMaceytB0G-C9KRhxQ5wxR7Mqdo98t_NbCUxDlts9orTzAVPNhqDAvPTydV4ED4h0UVq8LPtILoPX_zsN3KnVLc2gToJsMsY2wIWJuetfzRY_bzMce5cFPZ8VSFRbVVtoENlRKUtXChBGmBIkr7Rmm81ItSO7x6PmqOoZN4uh1h1wHnh5quBpdxeSVyvCQUjGyg7PYW6or2mUDxD_pk5nbUe9lvxBYaUiGbFs1hft5sBYbxw4GVuoq0dNhzg-29QbRSd3ibf0-ojkX-IVFnDB4b_B-YVYXpno6aIq6EBaw7xUfJnwxLjzp9Yc214ioUNSZusRD7SHCGE_oGQyHn_dhU5dMCa9GSTh-r8kIae9H5of8uMXJ4w9XjcGpspA3_d1t8Wlf98TfitguNprmX5i31dCkNzN5tD7_fPA5aIZq6vXTK9m0rAnlN5zUO_4qU_IYfOVHRHKnukmApU1nCCcqi-bBkBq3yN2yaGJjDDiYbQy_23j9cQBJ-5Hv5zsWbBCKdrWljQicncdjVGtp5UIAMcyIKYlwd80eO3vUkE5RhckXx6O_8BGRmqNG0WM_v25PDeQqqKLPxrQAjYD90BbIdBiZtCsudccjfB-STj7GAnzEwlJ7cw9Hi0RZjUj7OCEM8a-Km39IbdHrvhBrlDIC6qUJUigtAQP0ev0Jlqs3AAHIMc1LUyheBrjps5HCcSLfkgLBBYlY Document source: Rheumatology (Oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017220302407?via%3Dihub Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis Document link: https://www.jdsjournal.com/action/showPdf?pii=S0923-1811%2820%2930199-7 Document source: Journal of Dermatological Science Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: The effects of selected biologics and a small molecule on Health-Related Quality of Life in adult plaque psoriasis patients: A systematic review and meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7714099/pdf/pone.0241604.pdf Document source: PLoS One Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7843938/pdf/fmed-07-618163.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic Drug Survival in Psoriasis: A Systematic Review & Comparative Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC8012481/pdf/fmed-07-625755.pdf Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7286044/pdf/annrheumdis-2019-216656.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris – Part 1: treatment and monitoring recommendations Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16915 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2020

Document title: Biological therapy for pustular psoriasis: a systematic review Document link: https://onlinelibrary.wiley.com/doi/10.1111/ijd.14671 Document source: International Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933315-8 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC6956468/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Real-world evidence of secukinumab in psoriasis treatment - a meta-analysis of 43 studies Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16180 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review Document link: https://journals.sagepub.com/doi/10.1177/1203475419897578?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7218689/pdf/nihms-1069371.pdf Document source: Arthritis & Rheumatology (Hoboken, N.J.) Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Treatment of erythrodermic psoriasis with biologics: A systematic review Document link: https://linkinghub.elsevier.com/retrieve/pii/S0190-9622(20)30496-5 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://hal.sorbonne-universite.fr/hal-03894171v1/document Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcpt.13153 Document source: Journal of Clinical Pharmacy and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7216398/pdf/13075_2020_Article_2208.pdf Document source: Arthritis Research & Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis Document link: https://academic.oup.com/bjd/article-abstract/183/4/638/6761593?redirectedFrom=fulltext&login=false Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis Document link: https://journals.sagepub.com/doi/10.1177/1203475420933174?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017219300447?via%3Dihub Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2818%2933001-9 Document source: Journal of the American Academy of Dermatology Document type: Clinical Practice Guidelines Document year: 2019

Document title: 2019 Update of the American College of Rheumatology/Spondylitis association of America/Spondyloarthritis Research and Treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC6764857/pdf/nihms-1041470.pdf Document source: Arthritis & Rheumatology Document type: Clinical Practice Guidelines Document year: 2019

• Indicated for reducing signs and symptoms of Crohns disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
• Indicated for treatment of adults with moderately to severely active rheumatoid arthritis
• Indicated for treatment of adult patients with active psoriatic arthritis
• Indicated for treatment of adults with active ankylosing spondylitis
• Indicated for treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation
• Indicated for treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Document title: Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis Document link: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1376262/full Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysis Document link: https://advancesinrheumatology.biomedcentral.com/counter/pdf/10.1186/s42358-024-00361-3.pdf Document source: Advances in Rheumatology (london, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://ard.bmj.com/content/83/6/760.long Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Cimzia (certolizumab pegol) Prescribing Information. Document link: https://www.cimzia.com/themes/custom/cimzia/docs/CIMZIA_full_prescribing_information.pdf Document source: UCB, Inc., Smyrna, GA Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Dose Escalation Patterns of Advanced Therapies in Crohn's Disease and Ulcerative Colitis: A Systematic Literature Review Document link: https://link.springer.com/article/10.1007/s12325-023-02457-6 Document source: Advances in Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden Document link: https://www.tandfonline.com/doi/full/10.1080/13696998.2023.2259609 Document source: Journal of Medical Economics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons Document link: https://link.springer.com/article/10.1007/s40744-022-00522-0 Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment: An Individual Participant Data Meta-Analysis Document link: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.21398 Document source: Jama Network Open Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub6 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://rmdopen.bmj.com/content/8/1/e002074.long Document source: Rmd Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1743811 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: The Risk of Adverse Effects of TNF-alpha Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis Document link: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.814429/full Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Document link: https://link.springer.com/article/10.1007/s12325-022-02065-w Document source: Advances in Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: De-Escalation of Anti-Tumor Necrosis Factor Alpha Agents and Reduction in Adverse Effects: A Systematic Review Document link: https://www.mdpi.com/2227-9059/10/5/1034 Document source: Biomedicines Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Certolizumab pegol for maintenance of medically induced remission in Crohn's disease Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD013747.pub2 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis Document link: https://www.mdpi.com/1999-4923/14/10/2140 Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review Document link: https://www.jmcp.org/doi/10.18553/jmcp.2021.27.1.084?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Managed Care & Specialty Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Model-Based Meta-Analysis Compares DAS28 Rheumatoid Arthritis Treatment Effects and Suggests an Expedited Trial Design for Early Clinical Development Document link: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2023 Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies Document link: https://academic.oup.com/bjd/article-lookup/doi/10.1111/bjd.19314 Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data Document link: https://linkinghub.elsevier.com/retrieve/pii/S0190-9622(21)00422-9 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and Safety of Anti-TNFalpha Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis Document link: https://link.springer.com/article/10.1007/s40744-021-00296-x Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub4 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease Document link: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.655865/full Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S2468-1253(21)00312-5 Document source: The Lancet. Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis Document link: https://link.springer.com/article/10.1007/s40259-021-00507-5 Document source: Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub3 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis Document link: https://ard.bmj.com/content/79/6/744.long Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Patient characteristics as effect modifiers for psoriasis biologic treatment response: an assessment using network meta-analysis subgroups Document link: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-01395-6 Document source: Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: The pharmacological and clinical aspects behind dose loading of biological disease modifying anti-rheumatic drugs (bDMARDs) in auto-immune rheumatic diseases (AIRDs): rationale and systematic narrative review of clinical evidence Document link: https://bmcrheumatol.biomedcentral.com/articles/10.1186/s41927-020-00130-x Document source: Bmc Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials Document link: https://journals.lww.com/10.1097/MD.0000000000021447 Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Impact of tumor necrosis factor alpha inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis Document link: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0244788 Document source: Plos One Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S0049-0172(19)30044-7 Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Crohn's disease - treatment with biological medication. Document link: https://www.scielo.br/j/ramb/a/jGnwPn7tzsxFwMcZFFxQpbv/?lang=en Document source: Revista da Associação Médica Brasileira Document type: Clinical Practice Guidelines Document year: undefined

Document title: AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease. Document link: https://www.cghjournal.org/action/showPdf?pii=S1542-3565%2819%2930253-8 Document source: Journal of the Canadian Association of Gastroenterology Document type: Clinical Practice Guidelines Document year: undefined

Document title: AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease. Document link: https://www.gastrojournal.org/article/S0016-5085(21)00645-4/fulltext Document source: American Gastroenterological Association: Gastroenterology Document type: Clinical Practice Guidelines Document year: undefined

• Indicated for the treatment of rheumatoid arthritis (RA)
• Indicated for the treatment of polyarticular juvenile idiopathic arthritis (JIA) in patients aged 2 years or older
• Indicated for the treatment of Psoriatic Arthritis (PsA)
• Indicated for the treatment of ankylosing spondylitis (AS)
• Indicated for the treatment of plaque psoriasis (PsO) in patients 4 years or older.

Document title: Enbrel (etanercept) Prescribing Information. Document link: https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Enbrel/enbrel_pi_CURNT.pdf Document source: Amgen Inc., Thousand Oaks, CA Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Assessing Comparative Efficacy of Biologics for the Treatment of Psoriasis With Nail Involvement: A Systematic Review Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11361496/pdf/10.1177_24755303231217491.pdf Document source: Journal of Psoriasis and Psoriatic Arthritis Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta-Analysis Document link: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.42788 Document source: Arthritis & Rheumatology (hoboken, N.j.) Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia: a systematic review with meta-analysis Document link: https://rmdopen.bmj.com/content/10/1/e004016.long Document source: Rmd Open Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://ard.bmj.com/content/83/6/760.long Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysis Document link: https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-024-00361-3 Document source: Advances in Rheumatology (london, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: The Role of Etanercept in Controlling Clinical and Radiological Progression in Rheumatoid Arthritis: A Systematic Review Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11088797/pdf/cureus-0016-00000058112.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis Document link: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1376262/full Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand Document link: https://linkinghub.elsevier.com/retrieve/pii/S2212-1099(22)00192-3 Document source: Value in Health Regional Issues Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons Document link: https://link.springer.com/article/10.1007/s40744-022-00522-0 Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub6 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis Document link: https://rmdopen.bmj.com/content/9/4/e003468.long Document source: Rmd Open Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Inflammatory Bowel Disease Risk in Patients With Axial Spondyloarthritis Treated With Biologic Agents Determined Using the BSRBR-AS and a MetaAnalysis Document link: https://www.jrheum.org/content/50/2/175.long Document source: The Journal of Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1743811 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials Document link: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.847308/full Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub5 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: De-Escalation of Anti-Tumor Necrosis Factor Alpha Agents and Reduction in Adverse Effects: A Systematic Review Document link: https://www.mdpi.com/2227-9059/10/5/1034 Document source: Biomedicines Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review Document link: https://www.dovepress.com/biologics-can-significantly-improve-dermatology-life-quality-index-dlq-peer-reviewed-fulltext-article-PTT Document source: Psoriasis (auckland, N.z.) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and safety of biological agents for the treatment of pediatric patients with psoriasis: A bayesian analysis of six high-quality randomized controlled trials Document link: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.896550/full Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD013818.pub2 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis Document link: https://www.mdpi.com/1999-4923/14/10/2140 Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis Document link: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.754116/full Document source: Frontiers in Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Document link: https://academic.oup.com/rheumatology/article/61/9/e255/6594139 Document source: British Society for Rheumatology Document type: Clinical Practice Guidelines Document year: 2022

Document title: The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis Document link: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/keab630 Document source: Rheumatology (oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: The Risk of Adverse Effects of TNF-alpha Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis Document link: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.814429/full Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials Document link: https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-021-00514-4 Document source: Pediatric Rheumatology Online Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis Document link: https://link.springer.com/article/10.1007/s13555-021-00602-z Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study Document link: https://linkinghub.elsevier.com/retrieve/pii/S0049-0172(21)00156-6 Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials Document link: https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-021-02549-0 Document source: Arthritis Research & Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Fusion proteins of biologic agents in the treatment of rheumatoid arthritis (RA): A network meta-analysis Document link: https://journals.lww.com/10.1097/MD.0000000000026350 Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review Document link: https://link.springer.com/article/10.1007/s13555-021-00559-z Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub4 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and Safety of Anti-TNFalpha Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis Document link: https://link.springer.com/article/10.1007/s40744-021-00296-x Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data Document link: https://linkinghub.elsevier.com/retrieve/pii/S0190-9622(21)00422-9 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Model-Based Meta-Analysis Compares DAS28 Rheumatoid Arthritis Treatment Effects and Suggests an Expedited Trial Design for Early Clinical Development Document link: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2023 Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis Document link: https://www.tandfonline.com/doi/full/10.1080/1744666X.2020.1858803 Document source: Expert Review of Clinical Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Twelve-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post hoc analysis of six randomised trials Document link: https://onlinelibrary.wiley.com/doi/10.1111/jdv.16982 Document source: Journal of the European Academy of Dermatology and Venereology : Jeadv Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Relative efficacy and safety of tofacitinib for treating psoriasis: A Bayesian network meta-analysis of randomized controlled trials Document link: https://www.dustri.com/nc/article-response-page.html?artId=187468&doi= Document source: International Journal of Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Biological therapy in rheumatoid vasculitis: a systematic review Document link: https://link.springer.com/article/10.1007/s10067-020-05459-9 Document source: Clinical Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Document link: https://acrjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/art.41752 Document source: Arthritis Rheumatology Document type: Clinical Practice Guidelines Document year: 2021

Document title: Efficacy of Biologics Targeting Tumour Necrosis Factor-alpha, Interleukin-17 -12/23, -23 and Small Molecules Targeting JAK and PDE4 in the Treatment of Nail Psoriasis: A Network Meta-analysis Document link: https://medicaljournalssweden.se/actadv/article/view/1838 Document source: Acta Dermato-venereologica Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S0190-9622(19)33315-8 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Interventions for chronic palmoplantar pustulosis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011628.pub2 Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis Document link: https://ard.bmj.com/content/79/6/744.long Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis Document link: https://rmdopen.bmj.com/content/6/1/e001117.long Document source: Rmd Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologics in Leprosy: A Systematic Review and Case Report Document link: https://www.ajtmh.org:443/view/journals/tpmd/102/5/article-p1131.xml Document source: The American Journal of Tropical Medicine and Hygiene Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://ard.bmj.com/content/79/6/778.long Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review Document link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7494414/pdf/cureus-0012-00000009812.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials Document link: https://journals.lww.com/10.1097/MD.0000000000021447 Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis Document link: https://journals.sagepub.com/doi/10.1177/1060028019885836?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: The Annals of Pharmacotherapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Treatment guidelines in psoriatic arthritis. Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065461/ Document source: Rheumatology (Oxford, England) Document type: Clinical Practice Guidelines Document year: 2020

Document title: Joint AAD–NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. Document link: https://www.jaad.org/article/S0190-9622(20)32288-X/fulltext Document source: Journal of the American Academy of Dermatology Document type: Clinical Practice Guidelines Document year: 2020

Document title: Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks Document link: https://academic.oup.com/bjd/article-lookup/doi/10.1111/bjd.18232 Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S0049-0172(19)30044-7 Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

• Indicated for rheumatoid arthritis (RA): reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA
• Indicated for juvenile idiopathic arthritis (JIA): reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older
• Indicated for psoriatic arthritis (PsA): reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA
• Indicated for ankylosing spondylitis (AS): reducing signs and symptoms in adult patients with active AS
• Indicated for Crohns disease (CD): treatment of moderately to severely active Crohns disease in adults and pediatric patients 6 years of age and older
• Indicated for ulcerative colitis (UC): treatment of moderately to severely active ulcerative colitis in adult patients
• Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers
• Indicated for plaque psoriasis (Ps): treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate
• Indicated for hidradenitis suppurativa (HS): treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older
• Indicated for uveitis (UV): treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.

Document title: Efficacy and safety of adalimumab in pediatric patients with Crohn's disease: A systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10873464/pdf/228_2023_Article_3613.pdf Document source: European Journal of Clinical Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: An Overview of Adalimumab Therapy for Ankylosing Spondylitis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11340288/pdf/CRR-20-501.pdf Document source: Current Rheumatology Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11103324/pdf/ard-2024-225534.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative efficacy and therapeutic positioning of biologics in hidradenitis suppurativa: A systematic review with network meta-analysis of randomised trials Document link: https://ijdvl.com/view-pdf/?article=a7bd6044d869344e54a82205ee8597e70OL9hrfXiOgycw== Document source: Indian Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11148671/pdf/cureus-0016-00000061547.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review Document link: https://journals.sagepub.com/doi/epub/10.1177/12034754241260023 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Network meta-analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18110 Document source: Alimentary Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: The efficacy and safety of different Janus kinase inhibitors as monotherapy in rheumatoid arthritis: A Bayesian network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11192398/pdf/pone.0305621.pdf Document source: PLoS One Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11258201/pdf/HSR2-7-e2210.pdf Document source: Health Science Reports Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparison of adalimumab with methotrexate for psoriasis: A meta-analysis of randomized controlled studies Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11315506/pdf/medi-103-e37216.pdf Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Humira (adalimumab) Prescribing Information. Document link: https://www.simlandihcp.com/globalassets/simlandihcp/prescribing-information.pdf Document source: AbbVie Inc., North Chicago, IL Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125768/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277136/pdf/bmjophth-2023-001303.pdf Document source: BMJ Open Ophthalmology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2023.2249145?needAccess=true Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442954/pdf/fphar-14-1237234.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621919/pdf/pone.0293655.pdf Document source: PLoS One Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparison of Effectiveness and Safety of Ustekinumab and Adalimumab As Induction or Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226155/pdf/cureus-0015-00000038277.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Document link: https://academic.oup.com/ibdjournal/article-pdf/29/3/367/52523915/izac103.pdf Document source: Inflammatory Bowel Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis Document link: https://eprints.whiterose.ac.uk/190295/3/gutjnl-2022-328052R1%20CLEAN.pdf Document source: Gut Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative efficacy of advanced treatments in biologic-naive or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147762/pdf/11096_2022_Article_1509.pdf Document source: International Journal of Clinical Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951426/pdf/12969_2023_Article_798.pdf Document source: Pediatric Rheumatology Online Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naive Patients with Moderate-to-Severe Ulcerative Colitis in Japan Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085930/pdf/40273_2023_Article_1254.pdf Document source: Pharmacoeconomics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology Document link: https://www.dldjournalonline.com/action/showPdf?pii=S1590-8658%2823%2900484-X Document source: Digestive and Liver Disease Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany Document link: https://www.tandfonline.com/doi/epdf/10.1080/03007995.2023.2214046?needAccess=true Document source: Current Medical Research and Opinion Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220520/?report=printable Document source: JAMA Network Open Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224469/pdf/pharmaceutics-15-01351.pdf Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226205/pdf/12886_2023_Article_2987.pdf Document source: JAMA Netw Open Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systematic review of clinical practice guidelines for uveitis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827242/pdf/bmjophth-2022-001091.pdf Document source: BMJ Open Ophthalmology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication Document link: https://academic.oup.com/mr/article-pdf/33/1/21/49137216/roac017.pdf Document source: Modern Rheumatology Document type: Clinical Practice Guidelines Document year: 2023

Document title: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Document link: https://ard.bmj.com/content/annrheumdis/82/1/3.full.pdf?with-ds=yes Document source: Annals of the Rheumatic Diseases Document type: Clinical Practice Guidelines Document year: 2023

Document title: An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1744505?needAccess=true Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1743811 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics and small molecules in patients with scalp psoriasis: a systematic review Document link: https://pubmed.ncbi.nlm.nih.gov/32406275 Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1793891?needAccess=true Document source: Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2021.1892024?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629940/pdf/annrheumdis-2016-210459.pdf Document source: Modern Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies Document link: https://www.cghjournal.org/action/showPdf?pii=S1542-3565%2821%2900347-5 Document source: Clinical Gastroenterology and Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850822/pdf/cm9-135-011.pdf Document source: Chinese Medical Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357587/pdf/13555_2022_Article_760.pdf Document source: Dermatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913445/pdf/10067_2022_Article_6062.pdf Document source: Clinical Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798365/pdf/dic-2021-9-6.pdf Document source: Drugs in Context Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: The Risk of Adverse Effects of TNF-alpha Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888889/pdf/fimmu-13-814429.pdf Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Incidence of and Risk Factors for Paradoxical Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients Receiving Anti-TNF Therapy: Systematic Review With Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921985/pdf/fimmu-13-847160.pdf Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943739/pdf/rmdopen-2021-002074.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952692/pdf/jpm-12-00353.pdf Document source: Journal of personalized medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148207/pdf/ptt-12-99.pdf Document source: Medicine (Baltimore) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Adalimumab Effect on Pain in Hidradenitis Suppurativa Patients: Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116545/pdf/dp1202a99.pdf Document source: Lancet Gastroenterol Hepatol Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics and Small Molecule Inhibitors for Treating Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220298/pdf/biomedicines-10-01303.pdf Document source: Biomedicines Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254215/pdf/WJCC-10-6091.pdf Document source: World Journal of Clinical Cases Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402894/pdf/fphar-13-927179.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523983/pdf/40001_2022_Article_817.pdf Document source: European Journal of Medical Research Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562090/pdf/CD013818.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675210/pdf/12884_2022_Article_5191.pdf Document source: Gut Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis Document link: https://www.tandfonline.com/doi/epdf/10.1080/1744666X.2020.1858803?needAccess=true Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials Document link: https://pubmed.ncbi.nlm.nih.gov/34281633 Document source: International Journal of Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of adalimumab in hidradenitis suppurativa: A systematic review and meta-analysis of randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183777/pdf/medi-100-e26190.pdf Document source: BioDrugs Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109175/pdf/fphar-12-673984.pdf Document source: Pharmacoeconomics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080031/pdf/fphar-12-655865.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials Document link: https://www.jidonline.org/action/showPdf?pii=S0022-202X%2821%2901149-0 Document source: The Journal of investigative dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and Safety of Anti-TNFalpha Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217376/pdf/40744_2021_Article_296.pdf Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis Document link: https://www.tandfonline.com/doi/epdf/10.1080/17474124.2021.1880319?needAccess=true Document source: Expert Review of Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391184/pdf/jmcp.2021.27.1.084.pdf Document source: Journal of Managed care & Specialty Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of the efficacy and safety indicators of DMARDs for rheumatoid arthritis: A network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294891/pdf/medi-100-e26524.pdf Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991039/pdf/40744_2020_Article_259.pdf Document source: Rheumatology and Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review Document link: https://academic.oup.com/ecco-jcc/article/15/5/840/5904280?login=false Document source: Journal of Crohn's & Colitis Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Model-Based Meta-Analysis Compares DAS28 Rheumatoid Arthritis Treatment Effects and Suggests an Expedited Trial Design for Early Clinical Development Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894503/pdf/CPT-109-517.pdf Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933137/pdf/nihms-1787830.pdf Document source: The Lancet. Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials Document link: https://pubmed.ncbi.nlm.nih.gov/31781849 Document source: Zeitschrift fur Rheumatologie Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006886/pdf/CPT-107-435.pdf Document source: Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis Document link: https://www.jrheum.org/content/jrheum/47/1/59.full.pdf Document source: The Journal of Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933315-8 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011651/pdf/nihms-1680859.pdf Document source: Clinical Gastroenterology and Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318582/pdf/JDV-34-1050.pdf Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis Document link: https://pubmed.ncbi.nlm.nih.gov/31672037 Document source: The Annals of Pharmacotherapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic therapy for Behcet's uveitis: a systematic review Document link: https://pubmed.ncbi.nlm.nih.gov/31676596 Document source: British Journal of Ophthalmology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31945470/ Document source: Clinical Gastroenterology and Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: The benefit-risk balance for biological agents in juvenile idiopathic arthritis: a meta-analysis of randomized clinical trials Document link: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/keaa170 Document source: Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review Document link: https://pubmed.ncbi.nlm.nih.gov/31950853 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis Document link: https://www.tandfonline.com/doi/epdf/10.1080/03007995.2020.1716701?needAccess=true Document source: Current Medical Research and Opinion Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn's disease patients with perianal lesions: a systematic review Document link: https://air.unimi.it/retrieve/dfa8b9a1-6656-748b-e053-3a05fe0a3a96/PDF_Proof.PDF Document source: Expert Opinion on Biological Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286044/pdf/annrheumdis-2019-216656.pdf Document source: Annals of the Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32206624/ Document source: Pediatric Gastroenterology, Hepatology & Nutrition Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative efficacy and safety of 100 mg and 200 mg filgotinib administered to patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials Document link: https://pubmed.ncbi.nlm.nih.gov/32301699 Document source: International Journal of Clinical Pharmacology and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of anti-TNFalpha drugs in patients with stricturing Crohn's disease Document link: https://pubmed.ncbi.nlm.nih.gov/32351139 Document source: Expert Review of Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naive to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32371431/ Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials Document link: https://pubmed.ncbi.nlm.nih.gov/32483919 Document source: International Journal of Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis Document link: https://academic.oup.com/bjd/article-lookup/doi/10.1111/bjd.19325 Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis Document link: https://pubmed.ncbi.nlm.nih.gov/32588642 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis Document link: https://www.jdsjournal.com/action/showPdf?pii=S0923-1811%2820%2930199-7 Document source: Journal of Dermatological Science Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review Document link: https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.2311 Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017220302407?via%3Dihub Document source: Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Safety and efficacy of newer biologics DMARDs in the management of rheumatoid arthritis: A systematic review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718147/pdf/main.pdf Document source: Osteoarthritis and Cartilage Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: The effects of selected biologics and a small molecule on Health-Related Quality of Life in adult plaque psoriasis patients: A systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714099/pdf/pone.0241604.pdf Document source: PLoS One Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis Document link: https://pubmed.ncbi.nlm.nih.gov/31272807 Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758589/pdf/kez030.pdf Document source: Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894001/pdf/10.1177_2050640619883566.pdf Document source: United European Gastroenterology Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: A cost per responder analysis of secukinumab vs adalimumab for the treatment of ankylosing spondylitis from the Korean perspective Document link: https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.13635 Document source: International Journal of Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Treatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S1567576919312445?via%3Dihub Document source: International Immunopharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Different Original and Biosimilar TNF Inhibitors Similarly Reduce Joint Destruction in Rheumatoid Arthritis-A Network Meta-Analysis of 36 Randomized Controlled Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770755/pdf/ijms-20-04350.pdf Document source: International Journal of Molecular Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31617856/ Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: The Efficacy and Evidence-Based Use of Biologics in Children and Adolescents: Using Monoclonal Antibodies and Fusion Proteins as Treatments Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31711560/ Document source: Deutsches Arzteblatt International Document type: Systematic Reviews / Meta-Analyses Document year: 2019

• IIndicated for the treatment of adult patients with moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy
• Indicated for adults patient with active psoriatic arthritis (PsA)
• Indicated for adult patients with moderately to severely active Crohns disease (CD)
• Indicated for adult patients with moderately to severely active ulcerative colitis
• Indicated for the treatment of pediatric patients 6 years and older with moderate to severe plaque psoriasis, who are candidates for phototherapy or systemic therapy, or active psoriatic arthritis (PsA).

Document title: Stelara (ustekinumab) Prescribing Information. Document link: https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf Document source: Janssen Biotech, Inc., Titusville, NJ Document type: Product Monograph / Prescribing Information Document year: 2024

Document title: Response to Biologic Therapy in Skin of Colour Participants With Moderate-to-Severe Psoriasis and Atopic Dermatitis: A Systematic Review Document link: https://journals.sagepub.com/doi/pdf/10.1177/12034754241260023 Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis Document link: https://www.cghjournal.org/action/showPdf?pii=S1542-3565%2823%2900767-X Document source: Clinical gastroenterology and hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337265/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden Document link: https://www.tandfonline.com/doi/epdf/10.1080/13696998.2023.2259609?needAccess=true Document source: Journal of Medical Economics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Adverse Effects of Anti-Interleukin-23 Agents Employed in Patients with Psoriasis: A Systematic Review Document link: https://karger.com/drm/article/238/5/886/823440/Adverse-Effects-of-Anti-Interleukin-23-Agents Document source: Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics. Document link: https://www.minervamedica.it/en/getfreepdf/L1BkdUl3VVdDaitaSUZETVhUcW5ZS3NzT3EyeW1KYkFEa0lxOFRUZUdMQmFtOUR4SWdVb3pMWFVUTVU2ZnYvLw%253D%253D/R23Y2022N06A0469.pdf Document source: Italian Journal of Dermatology and Venereology Document type: Clinical Practice Guidelines Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2020.1743811?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis Document link: https://www.tandfonline.com/doi/epdf/10.1080/09546634.2021.1892024?needAccess=true Document source: The Journal of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056462/pdf/12325_2022_Article_2065.pdf Document source: Advances in Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017712/pdf/fphar-13-847308.pdf Document source: Frontiers in Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125768/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148207/pdf/ptt-12-99.pdf Document source: Psoriasis Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and safety of biological agents for the treatment of pediatric patients with psoriasis: A bayesian analysis of six high-quality randomized controlled trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446895/pdf/fimmu-13-896550.pdf Document source: Frontiers in Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608970/pdf/pharmaceutics-14-02140.pdf Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391184/pdf/jmcp.2021.27.1.084.pdf Document source: Journal of Managed Care & Specialty Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Impact of Biological Agents on Imaging and Biomarkers of Cardiovascular Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials Document link: https://www.jidonline.org/action/showPdf?pii=S0022-202X%2821%2901149-0 Document source: The Journal of Investigative Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494414/pdf/cureus-0012-00000009812.pdf Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review Document link: https://jamanetwork.com/journals/jamadermatology/article-abstract/2769110 Document source: JAMA Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis Document link: https://www.jdsjournal.com/action/showPdf?pii=S0923-1811%2820%2930199-7 Document source: Journal of Dermatological Science Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis Document link: https://journals.sagepub.com/doi/10.1177/1203475420933174?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jcpt.13153 Document source: Journal of clinical Pharmacy and Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046955/pdf/rmdopen-2019-001117.pdf Document source: RMD Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes Document link: https://www.clinexprheumatol.org/abstract.asp?a=14325 Document source: Clinical and Experimental Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review Document link: https://journals.sagepub.com/doi/10.1177/1203475419897578?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Journal of Cutaneous Medicine and Surgery Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956468/pdf/CD011535.pdf Document source: The Cochrane Database of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://www.jaad.org/action/showPdf?pii=S0190-9622%2819%2933315-8 Document source: Journal of the American Academy of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate-to-severe plaque psoriasis: the COMPASS analysis Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496582/pdf/BJD-183-276.pdf Document source: The British Journal of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biologic therapies targeting the interleukin (IL)-23/IL-17 immune axis for the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.15879 Document source: Journal of the European Academy of Dermatology and Venereology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title:  Japanese guidance for use of biologics for psoriasis (the 2019 version) Document link: https://onlinelibrary.wiley.com/doi/epdf/10.1111/1346-8138.15196 Document source: The Journal of Dermatology Document type: Clinical Practice Guidelines Document year: 2020

Document title: A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis Document link: https://pubmed.ncbi.nlm.nih.gov/32521069/ Document source: Dermatologic therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Document link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754904/pdf/JIR2019-2546161.pdf Document source: Journal of Immunology Research Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Treatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S1567576919312445?via%3Dihub Document source: International immunopharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis Document link: https://www.sciencedirect.com/science/article/abs/pii/S0049017219300447?via%3Dihub Document source: Seminars in Arthritis and Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2019

• Indicated for Crohns Disease: reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy, and reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients with fistulizing disease
• Indicated for pediatric Crohns Disease: reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of age and older with moderately to severely active disease who have had an inadequate response to conventional therapy
• Indicated for ulcerative colitis: reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
• Indicated for pediatric ulcerative colitis: reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of age and older with moderately to severely active disease who have had an inadequate response to conventional therapy
• Indicated for rheumatoid arthritis in combination with methotrexate: reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active disease
• Indicated for psoriatic arthritis: reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage, and improving physical function in adult patients
• Indicated for plaque psoriasis: treatment of adult patients with chronic severe (i.e., extensive and/or disabling) plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate
• Indicated for ankylosing spondylitis: reducing signs and symptoms in adult patients with active disease.

Document title: Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysis Document link: https://doi.org/10.1186/s42358-024-00361-3 Document source: Advances In Rheumatology (London, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis Document link: https://link.springer.com/article/10.1007/s40257-024-00849-0 Document source: American Journal Of Clinical Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative maintenance performance of all biologic agents and small molecules in ulcerative colitis: a network meta-analysis Document link: https://journals.lww.com/10.1097/MEG.0000000000002751 Document source: European Journal Of Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis Document link: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1376262/full Document source: Frontiers In Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Systematic review: effectiveness and safety of switching between originator infliximab and biosimilar infliximab in patients with inflammatory bowel disease Document link: https://www.tandfonline.com/doi/full/10.1080/14712598.2024.2378090 Document source: Expert Opinion On Biological Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials Document link: https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-024-03163-5 Document source: Bmc Gastroenterology Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis Document link: https://link.springer.com/article/10.1007/s10620-023-08252-1 Document source: Digestive Diseases And Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Document link: https://academic.oup.com/ecco-jcc/article-lookup/doi/10.1093/ecco-jcc/jjae059 Document source: Journal Of Crohn'S & Colitis Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Evaluating the Efficacy of Infliximab in Inflammatory Bowel Disease: A Systematic Review of the Literature Document link: https://doi.org/10.7759/cureus.65971 Document source: Cureus Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Document link: https://www.mdpi.com/1422-0067/25/11/5793 Document source: International Journal Of Molecular Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis Document link: https://ard.bmj.com/content/83/6/760.long Document source: Annals Of The Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2024

Document title: Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis Document link: https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02938-6 Document source: Bmc Gastroenterology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Infliximab Pricing in International Economic Evaluations in Inflammatory Bowel Disease to Inform Biologic and Biosimilar Access Policies: A Systematic Review Document link: https://journals.sagepub.com/doi/10.1177/23814683231156433?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Mdm Policy & Practice Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naive Patients with Moderate-to-Severe Ulcerative Colitis in Japan Document link: https://link.springer.com/article/10.1007/s40273-023-01254-x Document source: Pharmacoeconomics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis: A Systematic Review and Meta-analysis Document link: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.15872 Document source: Jama Network Open Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis Document link: https://www.nature.com/articles/s41598-023-40222-5 Document source: Scientific Reports Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Dose Escalation Patterns of Advanced Therapies in Crohn's Disease and Ulcerative Colitis: A Systematic Literature Review Document link: https://link.springer.com/article/10.1007/s12325-023-02457-6 Document source: Advances In Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub6 Document source: The Cochrane Database Of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis Document link: https://academic.oup.com/ibdjournal/article-lookup/doi/10.1093/ibd/izac200 Document source: Inflammatory Bowel Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: The comparative efficacy and safety of biologics and small molecules for treating patients with ulcerative colitis in Portugal: a systematic literature review and network meta-analysis Document link: https://www.europeanreview.org/article/33145 Document source: European Review For Medical And Pharmacological Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review Document link: https://www.mdpi.com/2076-0817/12/2/262 Document source: Pathogens (Basel, Switzerland) Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review Document link: https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-023-00798-8 Document source: Pediatric Rheumatology Online Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis Document link: https://www.dovepress.com/systematic-literature-review-of-real-world-evidence-on-dose-escalation-peer-reviewed-fulltext-article-CEOR Document source: Clinicoeconomics And Outcomes Research : Ceor Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology. Document link: https://www.dldjournalonline.com/article/S1590-8658(23)00166-4/fulltext Document source: Digestive and Liver Disease Document type: Clinical Practice Guidelines Document year: 2023

Document title: Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis Document link: https://gut.bmj.com/content/72/2/264.long Document source: Gut Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Comparative efficacy of advanced treatments in biologic-naive or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis Document link: https://link.springer.com/article/10.1007/s11096-022-01509-1 Document source: International Journal Of Clinical Pharmacy Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Network meta-analysis: efficacy and safety of treatments for fistulising Crohn's disease Document link: https://journals.lww.com/10.1097/MEG.0000000000002552 Document source: European Journal Of Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Infliximab for medical induction of remission in Crohn's disease Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD012623.pub2 Document source: The Cochrane Database Of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials Document link: https://academic.oup.com/ibdjournal/article-lookup/doi/10.1093/ibd/izac067 Document source: Inflammatory Bowel Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment Document link: https://academic.oup.com/ibdjournal/article-lookup/doi/10.1093/ibd/izac160 Document source: Inflammatory Bowel Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology Document link: https://linkinghub.elsevier.com/retrieve/pii/S1590-8658(23)00484-X Document source: Digestive And Liver Disease : Official Journal Of The Italian Society Of Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand Document link: https://linkinghub.elsevier.com/retrieve/pii/S2212-1099(22)00192-3 Document source: Value In Health Regional Issues Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden Document link: https://www.tandfonline.com/doi/full/10.1080/13696998.2023.2259609 Document source: Journal Of Medical Economics Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis Document link: https://journals.lww.com/10.1097/MD.0000000000031850 Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review Document link: https://www.mdpi.com/1999-4923/14/5/1009 Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis Document link: https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-022-02347-1 Document source: Bmc Gastroenterology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systematic review and meta-analysis: evaluating response to empiric anti-TNF dose intensification for secondary loss of response in Crohn's disease Document link: https://journals.sagepub.com/doi/10.1177/17562848211070940?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Therapeutic Advances In Gastroenterology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: The Risk of Adverse Effects of TNF-alpha Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis Document link: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.814429/full Document source: Frontiers In Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: The response to TNF blockers depending on their comparator in rheumatoid arthritis clinical trials: the lessebo effect, a meta-analysis Document link: https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/keab630 Document source: Rheumatology (Oxford, England) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes Document link: https://rmdopen.bmj.com/content/8/1/e002074.long Document source: Rmd Open Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S2468-1253(21)00377-0 Document source: The Lancet. Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials Document link: https://linkinghub.elsevier.com/retrieve/pii/S0016-5085(21)03709-4 Document source: Gastroenterology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis Document link: https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-022-05191-z Document source: Bmc Pregnancy And Childbirth Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials Document link: https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(21)01134-4 Document source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies Document link: https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(21)00347-5 Document source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologics Can Significantly Improve Dermatology Life Quality Index (DLQI) in Psoriatic Patients: A Systematic Review Document link: https://www.dovepress.com/biologics-can-significantly-improve-dermatology-life-quality-index-dlq-peer-reviewed-fulltext-article-PTT Document source: Psoriasis (Auckland, N.Z.) Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2021.1892024 Document source: The Journal Of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1744505 Document source: The Journal Of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis Document link: https://journals.lww.com/10.1097/CM9.0000000000001817 Document source: Chinese Medical Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2020.1743811 Document source: The Journal Of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis Document link: https://link.springer.com/article/10.1007/s12325-022-02065-w Document source: Advances In Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis Document link: https://www.mdpi.com/1999-4923/14/10/2140 Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub5 Document source: The Cochrane Database Of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease-A Systematic Literature Review Document link: https://www.mdpi.com/1999-4923/14/6/1241 Document source: Pharmaceutics Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn's Disease Document link: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.828219/full Document source: Frontiers In Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2022

Document title: Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis Document link: https://link.springer.com/article/10.1007/s40259-021-00507-5 Document source: Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals And Gene Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S2468-1253(21)00312-5 Document source: The Lancet. Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Anti-TNF and immunosuppressive combination therapy is preferential to inducing clinical remission in patients with active inflammatory bowel disease: A systemic review and meta-analysis Document link: https://onlinelibrary.wiley.com/doi/10.1111/1751-2980.13026 Document source: Journal Of Digestive Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis Document link: https://www.tandfonline.com/doi/full/10.1080/08820139.2020.1714650 Document source: Immunological Investigations Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis Document link: https://journals.sagepub.com/doi/10.1177/20406223211041927?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed Document source: Therapeutic Advances In Chronic Disease Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-alpha-Naive Patients With Moderate-to-Severe Ulcerative Colitis in China Document link: https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2021.704889/full Document source: Frontiers In Public Health Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systematic review: efficacy of escalated maintenance anti-tumour necrosis factor therapy in Crohn's disease Document link: https://doi.org/10.1111/apt.16479 Document source: Alimentary Pharmacology & Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review Document link: https://link.springer.com/article/10.1007/s13555-021-00559-z Document source: Dermatology And Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis Document link: https://www.tandfonline.com/doi/full/10.1080/1744666X.2020.1858803 Document source: Expert Review Of Clinical Immunology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systematic Review and Network Meta-Analysis: Comparative Efficacy and Safety of Biosimilars, Biologics and JAK1 Inhibitors for Active Crohn Disease Document link: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.655865/full Document source: Frontiers In Pharmacology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy Document link: https://academic.oup.com/ibdjournal/article-lookup/doi/10.1093/ibd/izaa073 Document source: Inflammatory Bowel Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review Document link: https://www.wjgnet.com/1007-9327/full/v27/i9/886.htm Document source: World Journal Of Gastroenterology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: The influence of biologics on the microbiome in immune-mediated inflammatory diseases: A systematic review Document link: https://linkinghub.elsevier.com/retrieve/pii/S0753-3322(21)00686-7 Document source: Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub4 Document source: The Cochrane Database Of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Remicade (infliximab) Prescribing Information. Document link: https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/REMICADE-pi.pdf Document source: Janssen Biotech, Inc., Titusville, NJ Document type: Product Monograph / Prescribing Information Document year: 2021

Document title: Anti -TNFalpha agents in preventing the postoperative recurrence of Crohn's disease: Do they still play a role in the biological era? Document link: https://www.tandfonline.com/doi/full/10.1080/14712598.2021.1964469 Document source: Expert Opinion On Biological Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis Document link: https://academic.oup.com/ecco-jcc/article-lookup/doi/10.1093/ecco-jcc/jjaa226 Document source: Journal Of Crohn'S & Colitis Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis Document link: https://doi.org/10.4103/sjg.sjg_145_21 Document source: Saudi Journal Of Gastroenterology : Official Journal Of The Saudi Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Review of treatments for generalized pustular psoriasis Document link: https://www.tandfonline.com/doi/full/10.1080/09546634.2019.1682502 Document source: The Journal Of Dermatological Treatment Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis Document link: https://gut.bmj.com/content/71/10/1976.long Document source: Gut Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis Document link: https://www.tandfonline.com/doi/full/10.1080/17474124.2021.1880319 Document source: Expert Review Of Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials Document link: https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(20)30615-7 Document source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysis Document link: https://academic.oup.com/ecco-jcc/article-lookup/doi/10.1093/ecco-jcc/jjaa139 Document source: Journal Of Crohn'S & Colitis Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(20)30847-8 Document source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Will the Inducing and Maintaining Remission of Non-biological Agents and Biological Agents Differ for Crohn's Disease? The Evidence From the Network Meta-Analysis Document link: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.679258/full Document source: Frontiers In Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Inflammatory Bowel Disease and Neutrophil-Lymphocyte Ratio: A Systematic Scoping Review Document link: https://www.mdpi.com/2077-0383/10/18/4219 Document source: Journal Of Clinical Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Systematic Review and Recommendations to Combine Newer Therapies With Conventional Therapy in Psoriatic Disease Document link: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.696597/full Document source: Frontiers In Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: A systematic review and meta-analysis Document link: https://journals.lww.com/10.1097/MD.0000000000027368 Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study Document link: https://linkinghub.elsevier.com/retrieve/pii/S0049-0172(21)00156-6 Document source: Seminars In Arthritis And Rheumatism Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: P014 Postoperative Recurrence in Crohn's Disease Patients Treated with Adalimumab versus Infliximab: A Systematic Review and Meta-Analysis Document link: https://journals.lww.com/10.14309/01.ajg.0000798656.34221.7f Document source: The American Journal Of Gastroenterology Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Network meta-analysis of infliximab biosimilars for the treatment of rheumatoid arthritis Document link: https://academic.oup.com/ajhp/article-lookup/doi/10.1093/ajhp/zxab042 Document source: American Journal Of Health-System Pharmacy : Ajhp : Official Journal Of The Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: CORRELATION BETWEEN TROUGH LEVELS OF INFLIXIMAB AND POSTOPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE PATIENTS SUBMITTED TO ILEOCOLONIC RESECTIONS: A SYSTEMATIC REVIEW Document link: https://www.scielo.br/j/ag/a/9XtPpy86ZR5GNP6YFZbXDBP/?lang=en Document source: Arquivos De Gastroenterologia Document type: Systematic Reviews / Meta-Analyses Document year: 2021

Document title: Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel Disease: A Systematic Review and Revised Dosing Considerations Document link: https://onlinelibrary.wiley.com/doi/10.1097/MPG.0000000000002631 Document source: Journal Of Pediatric Gastroenterology And Nutrition Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis Document link: https://link.springer.com/article/10.1007/s10067-020-04970-3 Document source: Clinical Rheumatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Number needed to treat and cost per remitter for biologic treatments of Crohn's disease in Japan Document link: https://www.tandfonline.com/doi/full/10.1080/13696998.2019.1642900 Document source: Journal Of Medical Economics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD011535.pub3 Document source: The Cochrane Database Of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis Document link: https://ard.bmj.com/content/79/6/744.long Document source: Annals Of The Rheumatic Diseases Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of anti-TNFalpha drugs in patients with stricturing Crohn's disease Document link: https://www.tandfonline.com/doi/full/10.1080/17474124.2020.1759417 Document source: Expert Review Of Gastroenterology & Hepatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease Document link: https://link.springer.com/article/10.1007/s10620-019-06036-0 Document source: Digestive Diseases And Sciences Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials Document link: https://linkinghub.elsevier.com/retrieve/pii/S2589-5370(20)30015-8 Document source: Eclinicalmedicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Management of Residual Psoriasis in Patients on Biologic Treatment Document link: https://jddonline.com/articles/dermatology/S1545961620P0188X Document source: Journal Of Drugs In Dermatology : Jdd Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn's disease patients with perianal lesions: a systematic review Document link: https://www.tandfonline.com/doi/full/10.1080/14712598.2020.1718096 Document source: Expert Opinion On Biological Therapy Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis Document link: https://journals.lww.com/10.1097/MD.0000000000022894 Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Patient characteristics as effect modifiers for psoriasis biologic treatment response: an assessment using network meta-analysis subgroups Document link: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-01395-6 Document source: Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(20)30044-6 Document source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systematic review: medical therapy for fibrostenosing Crohn's disease Document link: https://doi.org/10.1111/apt.15750 Document source: Alimentary Pharmacology & Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biological therapy for pustular psoriasis: a systematic review Document link: https://onlinelibrary.wiley.com/doi/10.1111/ijd.14671 Document source: International Journal Of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis Document link: https://linkinghub.elsevier.com/retrieve/pii/S0190-9622(19)33315-8 Document source: Journal Of The American Academy Of Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Biological therapy in pediatric age Document link: https://linkinghub.elsevier.com/retrieve/pii/S1043-6618(20)31428-6 Document source: Pharmacological Research Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease Document link: https://linkinghub.elsevier.com/retrieve/pii/S1542-3565(19)31493-4 Document source: Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies Document link: https://www.pghn.org/DOIx.php?id=10.5223/pghn.2020.23.2.121 Document source: Pediatric Gastroenterology, Hepatology & Nutrition Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis Document link: https://www.tandfonline.com/doi/full/10.1080/03007995.2020.1716701 Document source: Current Medical Research And Opinion Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease Document link: https://doi.org/10.1111/apt.15643 Document source: Alimentary Pharmacology & Therapeutics Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis Document link: https://rmdopen.bmj.com/content/6/1/e001117.long Document source: Rmd Open Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials Document link: https://journals.lww.com/10.1097/MD.0000000000021447 Document source: Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2020

Document title: Dose escalation and switching of biologics in ulcerative colitis: a systematic literature review in real-world evidence Document link: https://www.tandfonline.com/doi/full/10.1080/03007995.2019.1631058 Document source: Current Medical Research And Opinion Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis Document link: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2019.00338/full Document source: Frontiers In Medicine Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses Document link: https://onlinelibrary.wiley.com/doi/10.1177/2050640619883566 Document source: United European Gastroenterology Journal Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: ACG clinical guideline: ulcerative colitis in adults. Document link: https://journals.lww.com/ajg/Fulltext/2019/03000/ACG_Clinical_Guideline__Ulcerative_Colitis_in.10.aspx Document source: The American Journal of Gastroenterology Document type: Clinical Practice Guidelines Document year: 2019

Document title: Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. Document link: https://www.jaad.org/article/S0190-9622(18)33001-9/fulltext Document source: Journal of the American Academy of Dermatology Document type: Clinical Practice Guidelines Document year: 2019

Document title: Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease Document link: https://www.cochranelibrary.com/resolve/doi?DOI=10.1002/14651858.CD012804.pub2 Document source: The Cochrane Database Of Systematic Reviews Document type: Systematic Reviews / Meta-Analyses Document year: 2019

Document title: Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis Document link: https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2019.2941 Document source: Jama Dermatology Document type: Systematic Reviews / Meta-Analyses Document year: 2019

• Indicated for the topical treatment of plaque psoriasis in adults.

Document title: 1% Tapinarof cream for the treatment of psoriasis: a network meta-analysis of randomized placebo- and calcipotriol- controlled trials Document link: https://link.springer.com/article/10.1007/s00403-023-02749-5 Document source: Archives of Dermatological Research Document type: Systematic Reviews / Meta-Analyses Document year: 2023

Document title: Vtama (tapinarof) Prescribing Information. Document link: https://www.vtama.com/PI/ Document source: Dermavant Sciences Inc., Long Beach, CA Document type: Product Monograph / Prescribing Information Document year: 2022